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Menon, Jyothi, Ph.D., Purdue University, December 2015. Health Care Resource Use, 
Health Care Expenditures and Absenteeism Costs Associated with Osteoarthritis.  Major 
Professor: Joseph Thomas III. 
The objectives of this study were to determine incremental health care resource 
utilization, incremental health care expenditures, incremental absenteeism, and 
incremental absenteeism costs associated with Osteoarthritis.  An observational database 
analysis was conducted using information from the Medical Expenditure Panel Survey 
(MEPS).  Individuals 18 years of age or older and employed during 2011 were eligible 
for inclusion in the sample for analyses.  Individuals were identified with Osteoarthritis 
diagnosis based on ICD-9-CM diagnosis codes.  Out of a sample of 26,992 individuals, 
1,354 were diagnosed with osteoarthritis.  Individuals with osteoarthritis were compared 
to individuals without osteoarthritis.  
 Incremental health care resource utilization examined included annual 
hospitalization, annual hospital days, annual emergency room visits, annual outpatient 
visits.  Incremental health expenditures examined included annual inpatient expenditures, 
annual outpatient expenditures, annual emergency room expenditures, annual 
miscellaneous expenditures, annual medication expenditures and annual total 
expenditures.  Incremental resource utilization, incremental resource expenditures, 
incremental absenteeism and incremental absenteeism costs were estimated using 
xv 
 
regression models, adjusting for other covariates including age, gender, sex, region, 
marital status, insurance coverage, comorbidities, anxiety, asthma, hypertension and 
hyperlipidemia.  Multivariate regression models revealed incremental mean annual 
resource use associated with osteoarthritis of 0.07 hospitalizations, equal to 70 additional 
hospitalizations per 100 osteoarthritic patients annually, and 3.63 outpatient visits, equal 
to 363 additional visits per 100 osteoarthritic patients annually.  Mean annual incremental 
total expenditures associated with osteoarthritis were $2,046.  Mean annual incremental 
expenditures were largest for inpatient expenditures at $826, followed by mean annual 
incremental outpatient expenditures of $659, and mean annual incremental medication 
expenditures of $325.   Mean annual incremental absenteeism was 2.2 days and mean 
annual incremental absenteeism costs were $715.74.  
In conclusion, osteoarthritis was associated with considerable incremental health 
care resource utilization and expenditures.  Presence of osteoarthritis was also associated 








Musculoskeletal disease commonly causes chronic pain and disability (Chen, 
Gupte et al. 2012).  Due to increasing morbidity and mortality related to musculoskeletal 
diseases, the United Nations, the World Health Organization, and thirty-seven countries 
recognized the importance of  improving understanding and treatment of musculoskeletal 
disorders (Woolf and Pfleger 2003).  Arthritis is a prevalent musculoskeletal condition 
(Murray and Lopez 1997; Blixen and Kippes 1999) and is one of the causes of pain 
among older Americans (Chen, Gupte et al. 2012).  From 2010 to 2012, 49.7 percent of 
adults sixty-five years or older reported an arthritis diagnosis (Centers for Disease 
Control and Prevention 2013).  It is predicted that  by 2030, an estimated sixty-seven 
million Americans aged 18 years or older will be diagnosed with arthritis (Hootman and 
Helmick 2006).  Among all civilian, non-institutionalized United States adults between 
eighteen and sixty-four years of age, five percent (8.2 million) reported diagnosed 
arthritis and arthritis-attributable work limitations (Theis, Murphy et al. 2007).  Direct 
medical expenditures for arthritis and other rheumatic conditions in 2003 were estimated 
at eighty billion dollars (Centers for Disease Control and Prevention 2007).  Indirect costs 
including productivity losses for arthritis and other rheumatic conditions in 2003 were 
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estimated at forty-seven billion dollars (Centers for Disease Control and Prevention 
2007).   
Among different types of arthritis, osteoarthritis reportedly affects 27 million 
individuals in the United States (Lawrence, Felson et al. 2008).  Research for 
osteoarthritis have focused on direct costs including medications, hospitalizations, 
transport to and from the medical center, and ancillary medical devices (Woo, Lau et al. 
2003; Leardini, Salaffi et al. 2004; Gupta, Hawker et al. 2005; Kotlarz, Gunnarsson et al. 
2010).  Productivity losses or losses at work due to absenteeism or presenteeism because 
of osteoarthritis have also been examined (Woo, Lau et al. 2003; Leardini, Salaffi et al. 
2004; Gupta, Hawker et al. 2005).    
Literature Review 
Characteristics of Osteoarthritis 
Osteoarthritis is characterized by symptoms related to abnormalities in joints, 
subchondral bones and periarticular  structures (Altman, Alarcon et al. 1990).   
Individuals are diagnosed either due to pathological changes including joint space 
narrowing, and bony sclerosis, or due to the presentation of symptoms including pain, 
swelling or stiffness, or a combination of both (Altman, Alarcon et al. 1990).  In the 
United States, it was estimated that twenty-seven million adults suffered from 
osteoarthritis in 2005 (Lawrence, Felson et al. 2008).  Men have 45 percent lower risk of 
incident knee osteoarthritis and 36 percent lower risk of hip osteoarthritis than women 
(Srikanth, Fryer et al. 2005).  
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Osteoarthritis usually affect joints in the knee, hip, hand, spine and foot (Newman 
et al. 2003).  Among United States adults age thirty years or older, it has been estimated 
that symptomatic osteoarthritis in the knee occurs in 6 percent of individuals and 13 
percent in individuals who are sixty years old or older (Felson and Zhang 1998).   
Osteoarthritis of the knee or hip that often lead to significant problems with mobility are 
treated with expensive surgical treatments (Guccione, Felson et al. 1994).   Knee 
replacement surgeries due to osteoarthritis are one of the most commonly performed 
orthopedic procedures in the United States.  Approximately 50 percent of all joint 
arthroplasties performed on the knee, and 97 percent of those are performed for knee 
osteoarthritis (United States Bone and Joint Initiative 2011).  Osteoarthritis is expected to 
increase in the future in developed and developing countries due to increasing aging 
population and increasing prevalence of obesity, a risk factor of osteoarthritis (Badley 
and Wang 1998; March and Bagga 2004; Hagen, Zwart et al. 2005; Busija, Buchbinder et 
al. 2013). 
Risk factors  
Osteoarthritis and Age 
Prevalence of osteoarthritis increases with age (Felson, Naimark et al. 1987; 
Kallman, Wigley et al. 1990).   Felson and colleagues evaluated 1,424 individuals from 
the Framingham Heart study cohort whose ages ranged from sixty-three to ninety-four 
years.  The Framingham Heart Study investigated development of cardiovascular disease 
in an adult population of Framingham, Massachusetts.  Felson and colleagues evaluated 
these participants for the presence of knee osteoarthritis.  Osteoarthritis was diagnosed in 
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27 percent of individuals between 65 to 69 years and in 51 percent for individuals who 
were 85 years or older (Felson, Naimark et al. 1987).  Losina and colleagues estimated 
that approximately 10 percent of the United States population will be diagnosed with 
knee osteoarthritis by sixty years of age (Losina, Weinstein et al. 2013).  
Osteoarthritis and Gender 
Prevalence and incidence of osteoarthritis is significantly greater in women than 
men, especially after fifty years of age (Oliveria, Felson et al. 1995).  Felson and 
colleagues estimated that there was a slightly higher prevalence of osteoarthritis in 
women (34%) than in men (31%) (Felson, Naimark et al. 1987).   Zhang and colleagues 
examined 1,041 subjects older than seventy years of age and estimated a higher 
prevalence of hand osteoarthritis in women (26.2%) than in men (13.4%) (Zhang, Xu et 
al. 2001).   Srikanth and colleagues conducted a meta-analysis in differences between 
men and women with respect to osteoarthritis incidence.  Males as compared to females 
had a significantly reduced risk for osteoarthritis in the knee (Incidence Rate Ratio (IRR) 
of 0.55), but not in other joints (Srikanth, Fryer et al. 2005).   
Osteoarthritis and Race 
Anderson and Felson employed data from the HANES I survey which was the 
first national Health and Nutrition Examination Survey of 1971-1975, that examined a 
total of 5,193 individuals.  Black women, as compared to white women, had increased 
risk of osteoarthritis (odds ratio = 2.12, 95% confidence interval = 1.39 to 3.23) but no 
differences were observed between black men and white men (Anderson and Felson 
1988).  Sowers and colleagues examined 1,053 women for presence of osteoarthritis in 
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Michigan and reported higher prevalence of knee osteoarthritis in black women at 23.1 
percent than white women at 8.5 percent (Sowers, Lachance et al. 2000). 
Osteoarthritis and Genetic factors 
Research suggests that multiple genes and environmental factors can increase 
osteoarthritis susceptibility (Felson and Zhang 1998; Jonsson, Manolescu et al. 2003; 
Spector and MacGregor 2004).  At least 50 percent of cases of osteoarthritis in the hands, 
hips and spine are associated with genetic factors (Spector, Cicuttini et al. 1996).  Genes 
that are considered to have an association with risk of osteoarthritis include VDR, AGC1, 
IGF-1 and collagen II, IX, and XI (Spector and MacGregor 2004).  
Osteoarthritis and Occupation 
Occupational factors have been associated with risk of development of 
osteoarthritis.  In a textile mill in Virginia, female workers whose jobs required continual 
motion had a much higher rate of osteoarthritis than other female workers (Hadler, 
Gillings et al. 1978).  Felson and colleagues assessed the association between 
osteoarthritis in the knee and occupation of the individual.  Individuals whose jobs had 
repetitive knee motion had higher rate of knee osteoarthritis than men whose jobs did not 
include repetitive knee motion (odds ratio = 2.22) (Felson, Hannan et al. 1991).  Coggon 
and colleagues reported that farmers who regularly lifted weights in excess of ten 
kilograms had higher rates of hip osteoarthritis as compared to those who did not lift 
weights (odds ratio=3.2) (Coggon, Kellingray et al. 1998). 
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Osteoarthritis and Physical activity  
Buckwalter and Lane reported that  participation in sports that caused repetitive 
high levels of impact increased the risk of cartilage degeneration and caused osteoarthritis 
(Buckwalter and Lane 1997).  Buckwalter and Lane also suggested that people with 
abnormal joint alignment or joint injury had greater risk of osteoarthritis (Buckwalter and 
Lane 1997).  Kujala and colleagues selected 117 male former top-level athletes who had 
participated in different sports activities including long-distance running, soccer, weight 
lifters and shooters.  They reported increased premature risk of development of 
osteoarthritis in soccer players and weight lifters due to higher knee injuries (Kujala, 
Kettunen et al. 1995).  
Osteoarthritis and Comorbid disease conditions 
Caporali and colleagues evaluated 29,132 patients with osteoarthritis in Italy and 
reported that the most common comorbidities were hypertension (52 percent), 
osteoporosis (21 percent), type II diabetes mellitus (15 percent), and chronic obstructive 
pulmonary disease (12 percent) (Caporali et al 2005).  Marks and Allegrante examined 
1,000 hip osteoarthritis surgical patients and reported that 55 percent of the cohort had at 
least one comorbid condition related to an insufficiency of the cardiovascular, peripheral 
vascular or respiratory systems (Marks and Allegrante 2002).  Another risk factor for 
osteoarthritis is obesity (Felson, Lawrence et al. 2000; Runhaar, Koes et al. 2011).  Being 
overweight increases the risk of osteoarthritis (Oliveria, Felson et al. 1995).  In the 
Framingham Study, women who had a mean weight loss of eleven pounds  decreased 
their risk for knee osteoarthritis by 50 percent  (Felson, Zhang et al. 1992).  
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Comorbid conditions including obesity, cardiovascular diseases, anxiety, 
hypertension and diabetes have been associated with limitations in activities, and quality 
of life in osteoarthritis (Vebrugge, Gates et al. 1991; Creamer, Lethbridge-Cejku et al. 
2000; Carporali, Cimmano et al. 2005).   
Treatment for Osteoarthritis 
There is no treatment that can cure osteoarthritis. Treatment options include 
reducing pain and improving function of the joint.  Physical therapy, drug therapy and 
surgical interventions are some options for relieving pain.  Some pharmacological 
therapies include administering Nonsteroidal anti-inflammatory drugs (NSAIDs), which 
relieve pain and swelling (Tannenbaum, Peloso et al. 2000; Milder, Williams et al. 2011).   
NSAIDs are used as first-line treatment for moderate to severe osteoarthritis and 
work by inhibiting the COX pathway in the osteoarthritis joint (Tannenbaum, Peloso et 
al. 2000).  NSAIDs have been commonly prescribed with 80 percent of rheumatologists 
prescribing NSAIDs for osteoarthritis (Baum, Kennedy et al. 1985; Hochberg, Perlmutter 
et al. 1996).  There have been concerns regarding adverse effects due to NSAIDs, 
including NSAID related gastrointestinal ulcers (Graham 2000; Tang and Chan 2012).  
As a result, second generation COX-2 inhibitors were developed as safer alternatives.   
Opioids are becoming more common in treating osteoarthritis.  Rutjes and 
colleagues conducted a systematic literature review for individuals with osteoarthritis on 
pain, function and safety of oral or transdermal opioids as compared to patients with 
placebo.  They reported that while patients reported 50 percent greater improvement in 
pain with opioids than with placebo, there were also higher adverse events reported with 
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opioids as compared to placebo (Nuesch, Rutjes et al. 2009).  Since prescription opioids 
have been reported as a common source of opioid misuse, international osteoarthritis 
guidelines recommend use of opioids only in exceptional cases (Dunbar and Katz 1996; 
Zacny, Bigelow et al. 2003; Sproule, Brands et al. 2009; Zhang, Nuki et al. 2010).  
Other pharmaceutical agents used in the treatment of osteoarthritis are dietary 
supplements of glucosamine and chondroitin sulfate (Clegg, Reda et al. 2006),  
hyaluronic acid derivatives, NGF monoclonal antibodies (Lane, Schnitzer et al. 2010), 
growth factors (Sellers, Peluso et al. 1997), and stem cell therapy (Coleman, Curtin et al. 
2010).   
Physical rehabilitation is effective in improving symptoms of osteoarthritis 
(Ettinger, Burns et al. 1997; Rejeski, Focht et al. 2002).  Rejeski and colleagues reported 
that physical activity led  to an improvement in beliefs of individuals with osteoarthritis  
regarding performing their tasks (Rejeski, Ettinger et al. 1998).  Rejeski and colleagues  
randomly assigned 316 obese individuals with osteoarthritis to one of four interventions:  
weight loss due to dietary restrictions, exercise, dietary restrictions and exercise, or 
healthy lifestyle control for eighteen months.  The authors found that the individuals with 
combined diet and exercise intervention, had a significant increase in physical component 
summary score on the SF-36 instrument as compared to the control group (p<0.001).  
There were no significant differences between groups for the mental component 
summary score of the SF-36 (Rejeski, Focht et al. 2002).   
Surgical treatment is employed when there is serious damage or pain in the 
affected joint (Ronn, Reischl et al. 2011).  Surgery may involve repair of the joint 
through small incisions.  Joint replacement is conducted if damage cannot be repaired 
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through incisions (Fortin, Penrod et al. 2002; Bruyere, Pavelka et al. 2008; Ronn, Reischl 
et al. 2011).  
Osteoarthritis and health-related quality of life 
Pain due to osteoarthritis causes functional limitations, stress, depression, and 
interferes with performance of various life roles (Gignac, Backman et al. 2008; Sale, 
Gignac et al. 2008).  Salaffi and colleagues compared individuals suffering from 
osteoarthritis with healthy individuals and evaluated their health-related quality of life 
using the Short Form-36 (SF-36).   One hundred and forty-five patients (54.9 percent) out 
of 264 patients reported at least one chronic comorbid disease.  Individuals with 
osteoarthritis reported significantly lower scores for physical functioning domain (mean 
score =48.2) (p<0.001) as compared to individuals without osteoarthritis (mean 
score=79.2) (Salaffi, Carotti et al. 2005).  
 Similarly, Jakobsson and Hallberg conducted a literature review on pain and 
health-related quality of life among people aged seventy-five years and older with 
osteoarthritis.  They reported that individuals with osteoarthritis had more pain, 
functional limitations, and lower physical quality of life than those without osteoarthritis 
(Jakobsson and Hallberg 2006).   
DiBonaventura and colleagues compared individuals with osteoarthritis and 
individuals without osteoarthritis using data from the 2009 National Health and Wellness 
Survey.  There were 2,173 individuals who reported osteoarthritis and 37,599 individuals 
without osteoarthritis.   Individuals suffering from osteoarthritis (mean age of 52.1 years) 
were significantly older than individuals without osteoarthritis (mean age of 41.4 years) 
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(p< 0.0001).  Most of the individuals were predominantly females (58.2 percent).  There 
was higher impairment in work for individuals with osteoarthritis (34.4 percent) as 
compared to individuals without osteoarthritis (17.8 percent, p<0.001) (Dibonaventura, 
Gupta et al. 2011). 
Individuals with osteoarthritis have been reported to suffer from higher levels of  
depression as compared to individuals without osteoarthritis (Maisiak 1990; Kim, Han et 
al. 2011).  Apart from the fact that pain in osteoarthritis limits functioning, it also deters a 
person from carrying out personal and social functions.  This could, in turn, lead to 
further depression and anxiety (Williamson and Shaffer 2000).   
In summary, three studies reported lower physical functioning among individuals 
with osteoarthritis than individuals without osteoarthritis (Salaffi, Carotti et al. 2005; 
Jakobsson and Hallberg 2006; Dibonaventura, Gupta et al. 2011).  Three studies reported 
lower mental functioning among individuals with osteoarthritis than individuals without 
osteoarthritis (Maisiak 1990; Williamson and Shaffer 2000; Kim, Han et al. 2011; 
Gignac, Backman et al. 2013).  
Direct resource utilization and expenditures  
All-cause direct utilization and costs for individuals with osteoarthritis  
Direct costs are expenditures associated with interventions or treatments for  
hospital care, physician services, equipment, medications and laboratory studies (Gabriel, 
Crowson et al. 1997).  White and colleagues analyzed a de-identified claims data base for 
privately insured members between 1998 and 2004.   Individuals older than eighteen and 
younger than sixty-four years of age and having at least two claims of osteoarthritis 
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diagnosis were included.  A total of 32,043 osteoarthritis patients comprised the study 
sample.  Mean age for the total sample was fifty-five years, and sixty percent of the 
sample was female.  For annual medical utilization, the mean all-cause outpatient visits 
was 26.11 with standard deviation of 25.89, the mean all-cause inpatient hospitalization 
was 0.60 with standard deviation of 1.57 and the mean all-cause emergency room 
utilization was 0.30 with standard deviation of 1.57.  Mean all-cause expenditure for 
patients diagnosed with osteoarthritis annually was estimated at $8,601 (White, Birnbaum 
et al. 2008). 
Osteoarthritis-related utilization and cost 
Osteoarthritis-related utilization and costs, survey-based studies 
Gupta and colleagues mailed a screening questionnaire to individuals older than 
fifty-five years in Ontario, Canada to obtain information on self-reported arthritis.  
Individuals who reported suffering from osteoarthritis were requested to participate in a 
five-year follow up study.  Individuals provided their demographic information, health 
status,  whether they had physician diagnosed arthritis and whether they had joint 
replacement through a self-reported questionnaire.  Patients were asked to 
report the actual costs for the health care services and medical equipments used.  Using 
information from the questionnaire, osteoarthritis related direct costs in this study were 
calculated as sum of equipment, transport, homecare, home aide care, and other 
expenditures due to arthritis.  Costs due to prescription and non-prescription drugs were 
not included, as  Canada provides public insurance that covers medication charges.  Mean 
direct costs were $2,300 per person  per year.  Logistic regression was used to analyze 
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any osteoarthritis-related costs.   Age, gender, race, body mass index, income, 
employment, education were included in the analyses as predictors to determine the 
likelihood of reporting any osteoarthritis related costs.  Older individuals as compared to 
younger individuals were more likely to have osteoarthritis-related costs (p<0.001). 
Women were more likely than men to having osteoarthritis-related costs (p<0.001) 
(Gupta, Hawker et al. 2005).   
  Woo and colleagues estimated osteoarthritis related direct utilization and  costs 
of osteoarthritis in Hong Kong in 2001.  Patients with osteoarthritis were recruited from 
four different types of clinic of Hong Kong.  Participants were given a questionnaire that 
collected data on sociodemographic information and information on disease.  Information 
on all hospital or clinic services related to osteoarthritis in the past twelve months was 
collected.  Means and standard deviations for costs and utilization for groups with mild  
osteoarthritis and severe osteoarthritis were calculated.  Direct costs of osteoarthritis were 
summation of costs due to hospital inpatient and outpatient services, drug treatments, 
transport to hospital or clinic for the previous twelve months for osteoarthritis.  Mean 
emergency visits annually for osteoarthritis were 1.8 days,  mean outpatient visits 
annually for osteoarthritis were 3.4 days, mean duration of hospitalization visits annually 
for osteoarthritis were  36.1 days,  mean duration of physiotherapy visits annually for 
osteoarthritis were 19.7 days, and average duration of occupational therapy annually for 
osteoarthritis were 18.8 days.  Average direct costs for a person per year ranged from 
$192 dollars for mild osteoarthritis to $658 Hong Kong dollars for severe osteoarthritis 
(Woo, Lau et al. 2003).   
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Leardini and colleagues evaluated a cohort of 254 patients from twenty-nine 
rheumatology institutes  suffering from osteoarthritis in Italy from 2000 to 2001.  Patients 
in the rheumatology institutes reported to a rheumatologist in each institute.  Data 
collection was conducted by the rheumatologists who obtained information on the 
patient’s  sociodemographic characteristics and clinical information about the disease 
with a survey.  Direct costs related to osteoarthritis including hospitalizations, visits to 
general practioners, specialists, laboratory examinations, and physical therapies were 
obtained from the survey and summed.  Mean age of the sample was sixty-six years, and 
75 percent of the sample were females.  Mean direct costs per person annually was 
calculated.  The authors reported mean direct cost of €934 ($1,061) per patient per year, 
which included €233 ($256) spent on hospitalization,  €209 ($230)  on diagnostic 
procedures, and  €146 ($160) on  drug therapy (Leardini, Salaffi et al. 2004).    
In summary, three studies found osteoarthritis-related costs using survey data 
(Woo, Lau et al. 2003; Leardini, Salaffi et al. 2004; Gupta, Hawker et al. 2005).  The 
range of osteoarthritis related direct total costs was between $192 (Woo, Lau et al. 2003) 
to $2,300 (Gupta, Hawker et al. 2005) per person annually. The range in costs can be 
attributed to the different medical insurance systems that are present in different 
countries.   
Osteoarthritis-related utilization and costs, claims data 
Lanes and colleagues evaluated arthritis related direct costs for patients with 
osteoarthritis or rheumatoid arthritis from July 1, 1993 to June 30, 1994.  Medical records 
of patients were obtained from records of a group-model health maintenance 
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organization.  Utilization included hospital care, outpatient visits and prescriptions.  
Individuals thirty years and older, with either rheumatoid arthritis and osteoarthritis  and 
who were actively enrolled between July 1, 1993 and June 30, 1994 were included.  
Individuals diagnosed with rheumatoid arthritis were 365 in number and individuals with 
osteoarthritis were 10,101 in number.  Mean costs for medication, office visits, 
ambulatory visit, and inpatient costs from the utilization records were calculated.  An 
average individual direct cost of $543 was attributed for osteoarthritis per year while an 
average individual direct cost for rheumatoid arthritis was $2,162 annually.  Hospital care 
was an average cost of $249 per person per year (Lanes, Lanza et al. 1997). 
Dunn and colleagues employed data from the IMS or Pharmetrics Integrated 
Patient-Centric Database, which are medical and pharmaceutical claims from many 
health plans across the United States.  Inclusion criteria were a diagnosis of osteoarthritis 
from January 1, 2007 through December 31, 2007 and being continuously enrolled for a 
year.  The sample included 1,116,437 eligible participants with average age of fifty-four 
years.  Means and standard deviations for inpatient costs, outpatient costs, prescription 
medications, and emergency department visits for individuals with osteoarthritis were 
calculated from claims.   More than half of the sample (56%) were fifty years and older in 
age, and 60 percent of the sample were females.  Mean inpatient visit annually was one 
visit, mean outpatient visit annually were fifteen visits, mean emergency rooms visits 
annually were 0.2 visits, and mean medications prescribed annually were 3.8 
medications.  Average charges annually due to osteoarthritis were estimated to be $5,398 
per patient with nearly 40 percent of total charges due to inpatient costs (Dunn and Pill 
2009).   
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In summary, two studies evaluated osteoarthritis-related utilization and 
expenditures using claims data.  The average costs annually due to osteoarthritis varied 
between $543 per person per year (Lanes, Lanza et al. 1997) to $5,398 per patient per 
year (Dunn and Pill 2009).  Difference between expenditures can be attributed due to fact 
that Dunn and Pill calculated charges submitted by providers and not actual payer costs 
while Lanes et al. calculated costs by actual payers.  
Incremental direct costs 
Incremental utilization and costs, matched cohort analyses 
Berger and colleagues examined  incremental direct costs for osteoarthritis using 
MarketScan® commercial database in the United States (Berger, Hartrick et al. 2011).  
Private-sector employees, aged eighteen years or older osteoarthritis in 2007 were 
examined.  Individuals aged eighteen years or younger,  uninsured, or Medicaid 
beneficiaries were excluded.  Direct care costs were estimated as summation of  costs due 
to inpatient visits, outpatient visits that included physician visits and emergency 
department visits, hospitalizations, and prescription medications.  Employed persons with 
osteoarthritis were identified (2,399 individuals) and matched on age and sex to an equal 
number of individuals without osteoarthritis.   Mean age of the sample was 53 years, and 
62 percent of the sample were men.   Individuals with osteoarthritis also had significanly 
higher outpatient visits (28.5 visits) and hospitalizations (0.4 visits) as compared to 
individuals without osteoarthritis (11.8 visits) and hospitalizations (P < 0.01).  
Individuals with osteoarthritis also had significanly higher hospitalizations (0.4 visits) as 
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compared to individuals without osteoarthritis (0.1 visits) (P < 0.01).  Annual incremental 
cost associated with osteoarthritis was $8,060 per person (Berger, Hartrick et al. 2011). 
A study by Macclean and colleagues estimated incremental direct costs due to 
osteoarthritis using insurance claims from 1991 and 1993 in a national managed care 
organization.  Patients with osteoarthritis were matched on age and sex to subjects who 
had no insurance claims for osteoarthritis.  The sample consisted of 10,000 individuals 
with osteoarthritis who were matched to an equal number of individuals without 
osteoarthritis on age, sex, and insurance plan.  Direct care costs were summation of  costs 
due to inpatient visits, outpatient visits that included physician visits and emergency 
department visits, hospitalizations, and prescription medications.  Mean annual direct 
costs for individuals with osteoarthritis were $5,294 and  mean annual direct costs for 
individuals without osteoarthritis were $2,467.  Incremental annual direct cost per person 
associated with osteoarthritis was $2,827 (MacLean, Knight et al. 1998).   
In summary, two studies reported incremental costs associated with osteoarthritis.  
Incremental costs associated with osteoarthritis ranged from $2,287 (MacLean, Knight et 
al. 1998) to $8,060 per person per year (Berger, Hartrick et al. 2011).   Both studies did 
not incorporate comorbid disease conditions while reporting incremental estimates.  
Maclean et al. conducted their study in 1993, while Berger et al. conducted their studies 
in 2011 respectively.  Increased expenditures from the study conducted by Maclean et al. 
to Berger et al. can be attributed to the increasing costs of medical services with time.  
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Incremental utilization and costs, regression analyses 
Le and colleagues included individuals older than eighteen years of age with an 
osteoarthritis claim in 2007 using MarketScan® Commercial and Medicare Supplemental 
Databases.  Direct costs were compared between individuals with osteoarthritis and 
individuals without osteoarthritis.  Individuals with an osteoarthritis diagnosis on an 
inpatient or outpatient claim in 2007 were included in the study.  The number of 
individuals in the study with osteoarthritis was 258,237 patients who were matched to 
individuals without osteoarthritis on age, gender, geographic region, health plan type, and 
Medicare eligibility.  Generalized linear model regressions estimated hospitalizations and 
expenditures.  Incremental annual mean hospitalizations was 0.3 (p<0.05), incremental 
annual mean emergency room visits was 0.2 (p<0.05) and incremental annual mean 
outpatient visits was 2.9 (p<0.05).  Incremental annual direct cost due to osteoarthritis per 
person was $10,941 (Le, Montejano et al. 2012). 
DiBonaventura and colleagues used 2009 National Health and Wellness Survey to 
estimate direct medical costs of employed individuals in the U.S.  Individuals indicated in 
the survey if they suffered from arthritis and the type of arthritis they suffered.  Of the 
39,772 individuals, 2,173 were diagnosed with osteoarthritis.  Mean age of individuals 
without osteoarthritis was 41 years and mean age of individuals with osteoarthritis was 
52 years.  More than half of the sample with osteoarthritis were females (58.2 percent), 
while 46 percent of individuals with no osteoarthritis were females.  Individuals who 
reported osteoarthritis were compared to individuals without osteoarthritis.  Resource 
utilizations estimated were prescriptions, outpatient visits, hospitalizations and 
emergency room visits.  Direct mean annual costs were $3,702 for individuals with 
18 
osteoarthritis and $2,158 for individuals without osteoarthritis. Mean annual cost 
associated with osteoarthritis was estimated at $1,544 per person.  (Dibonaventura, Gupta 
et al. 2011). 
Kotlarz and colleagues used data 1996 to 2005 from the Medical Expenditure 
Panel Survey (MEPS) and calculated direct costs for individuals with osteoarthritis and 
individuals without osteoarthritis.  Individuals eighteen years or older were included in 
the study.  Generalized linear models were conducted to estimate incremental direct costs 
using a zero inflated negative binomial distribution model.  Hospital, outpatient, 
medication and related medical expenditures were estimated.  The authors estimated costs 
separately for men and women.  The study sample included 74,603 women and 53,890 
men.  Out-of-pocket direct costs and costs attributable to insurers were calculated.  
Among women, there was an increase of out of pocket expenditures by $1,379 per 
woman per year due to osteoarthritis and insurer expenditures by $4,833 per person per 
year.  There was an increase of out-of-pocket expenditures by $694 per man per year due 
to osteoarthritis and insurer expenditures by $4,036 per person per year (Kotlarz, 
Gunnarsson et al. 2009). 
In summary, three studies examined osteoarthritis related incremental direct costs 
(Dibonaventura et al 2011; Kotlarz et al. 2009; Le et al. 2012).   Kotlarz et al. did not 
estimate an annual direct cost per person and instead estimated an average direct cost for 
females ($1,379) out-of- pocket and males ($694) out-of-pocket, separately.    
19 
Indirect expenditures associated with osteoarthritis 
Indirect expenditures are defined as expenses incurred from the cessation or 
reduction of work productivity as a result of morbidity and mortality associated with a 
given disease (Gupta, Hawker et al. 2005).  Indirect costs  consist of reduced productivity 
from illness, and costs accrued by family and friends for taking care of an individual due 
to his or her disease (Andersson, Levin et al. 2002).  Indirect costs incurred due to 
absenteeism from the workplace are referred to as absenteeism costs (Andersson, Levin 
et al. 2002).  
Absenteeism costs 
 Work productivity has been defined as production output per labor hours (Beaton, 
Bombardier et al. 2009).  Loss of work productivity can be due to days missed from work 
(absenteeism), or difficulties experienced at work due to illness (presenteeism) (Brouwer, 
Koopmanschap et al. 1999; Meerding, Jzelenberg et al. 2005).   Absenteeism costs are 
commonly determined by calculating number of working days lost due to illness and 
multiplying with market wage rates (Beaton, Bombardier et al. 2009).     
All-cause absenteeism associated with osteoarthritis  
White and colleagues analyzed a claims database for privately insured members 
from 1998 to 2004 in the United States.  In order to calculate absenteeism, the authors 
counted a hospital outpatient visit as a half day of absenteeism and a hospital inpatient 
visit as a full day of absenteeism.  Individual’s daily wage was multiplied with days 
absent to obtain absenteeism costs.  Average annual absenteeism costs for individuals 
with osteoarthritis were $4,603 (White, Birnbaum et al. 2008).    
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Osteoarthritis-related absenteeism 
Leardini and colleagues evaluated a cohort of 254 patients from twenty-nine 
rheumatology institutes  suffering from osteoarthritis in Italy from 2000 to 2001.  Patients 
in the rheumatology institutes reported to a rheumatologist in each institute  who obtained 
information on the patient’s  sociodemographic characteristics and clinical information 
about the disease.  Information was collected from patients about the number of working 
days lost in the past year due to osteoarthritis.   Average wages of individuals in different 
occupations were obtained from the National Statistics Institute of Italy.  Annual working 
days missed due to osteoarthritis was multiplied with daily wages to obtain absenteeism 
costs.   Patients who reported absenteeism due to osteoarthritis reported missing twenty-
five working days in the past year, on an average.  Absenteeism costs were €1,236 
($1,360)  per year per patient (Leardini, Salaffi et al. 2004).    
Woo and colleagues estimated absenteeism costs of osteoarthritis in Hong Kong 
in 2001 for individuals with mild and severe osteoarthritis.  Patients with a diagnosis of 
osteoarthritis were recruited from different medical clinics.   In the survey, participants 
provided information related to sick days absent from work due to osteoarthritis.  
Participants also provided information about their wage rates.  The authors reported that 
for individuals with mild arthritis, the average annual costs due to absenteeism or 
retirement or change in jobs were $422 and for severe arthritis due to absenteeism or 
retirement or change in jobs, the average annual costs were $850 (Woo, Lau et al. 2003).    
Gupta and colleagues evaluated  absenteeism costs among 1,258 individuals 
suffering osteoarthritis in Canada.  The authors asked individuals to report the amount of 
time they had taken off from work in the past three months due to osteoarthritis.  Wages 
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lost due to absenteeism were obtained by using occupation specific wages from 2001 
Canadian census and were multiplied with number of working days missed at work.   
Mean absenteeism costs were $7,905 per person per annum (Gupta, Hawker et al. 2005).  
Osteoarthritis-related incremental absenteeism, regression approach 
Kotlarz and colleagues used Medical Expenditure Panel Survey (MEPS) data of 
employees in the United States to examine association between osteoarthritis and 
absenteeism costs from 1996 to 2005.  There were 56,379 women and 61,424 men in the 
study.  Individuals annual wages were multiplied with annual days missed at workplace 
to estimate absenteeism costs.  Generalized linear models were conducted to estimate 
incremental direct costs using a zero inflated negative binomial model.  Variables 
included in the analysis were age, occupation, race, gender, region, education, marital 
status, presence of diseases including hypertension and hyperlipidemia.  Incremental 
annual absenteeism associated with osteoarthritis for women was 3.7 days per woman.  
Similarly, incremental annual absenteeism associated with osteoarthritis for men was 4.5 
days per man.   Incremental annual absenteeism costs associated with osteoarthritis for 
women were $469 per woman.  Similarly, incremental annual absenteeism costs 
associated with osteoarthritis for men were $520 per man.   (Kotlarz, Gunnarsson et al. 
2010).  
Berger and colleagues examined absenteeism costs using MarketScan® 
commercial database.  Employees, aged eighteen years or older with osteoarthritis in 
2007 were examined.  Absenteeism costs were obtained by multiplying  number of hours 
absent from work by the mean hourly wage of US full-time civilian employees in 2007 
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estimated at $21.08 in year 2007 from United States census.  Incremental annual 
absenteeism associated with osteoarthritis was 1.8 days.  The authors also reported that 
average annual absenteeism cost for individuals with osteoarthritis was $3,165, as 
compared to average annual absenteeism cost for individuals without osteoarthritis at 
$1,747, with incremental absenteeism costs at $1,418 (Berger, Hartrick et al. 2011).   
DiBonaventura and colleagues used 2009 National Health and Wellness Survey to 
estimate productivity costs in the U.S.  Individuals reported absenteeism from their 
workplace during the previous seven days.  For absenteeism costs, average annual 
income values were obtained from the Bureau of Labor Statistics, and then multiplied 
with number of days missed at work.  Individuals with osteoarthritis were compared to 
individuals without osteoarthritis.  Incremental annual absenteeism costs were $5,328 
(Dibonaventura, Gupta et al. 2011).     
There are variations in how absenteeism costs were calculated in literature. While 
Kotlarz et al., (Kotlarz, Gunnarsson et al. 2010) and Woo et al.(Woo, Lau et al. 2003),  
employed earnings as reported by individuals,  DiBonaventura et al.(Dibonaventura, 
Gupta et al. 2011), Berger et al. (Berger, Hartrick et al. 2011), Leardini et al. (Leardini, 
Salaffi et al. 2004), and Gupta et al. (Gupta, Hawker et al. 2005) used estimated average 
wages from census data to estimate absenteeism costs.  Studies that used average wages 
from census data reported higher absenteeism costs in general than studies that used 
wages reported by individuals.  
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Study Rationale 
Maetzel and colleagues suggested that economic burden of  arthritic conditions, 
primarily osteoarthritis, will increase as the working population generation gets older 
(Maetzel, Li et al. 2004).  Kotlarz and colleagues examined absenteeism costs for 
employed individuals suffering from osteoarthritis from 1996 to 2005 from the Medical 
Expenditure Panel Survey (MEPS) (Kotlarz, Gunnarsson et al. 2010).  Berger et al., and 
Le et al. also calculated direct and absenteeism costs using Marketscan claims data for 
2007 (Berger, Hartrick et al. 2011; Le, Montejano et al. 2012).  Berger et al. and Le et al. 
however did not adjust for comorbid disease conditions while analyzing incremental 
direct expenditures for osteoarthritis.  The authors reported that adjusting for comorbid 
diseases for individuals with osteoarthritis in future research, would help determine 
expenditures attributable solely to osteoarthritis (Berger, Hartrick et al. 2011).  The 
current study estimated incremental utilization and incremental costs of direct healthcare 
associated with osteoarthritis as well as incremental absenteeism and incremental 
absenteeism costs associated with osteoarthritis. 
Significance 
Current estimates of the economic burden of osteoarthritis ignore the cost of some 
therapies such as physical therapy and chiropractic care.  Current estimates may likely 
underestimate the impact of the disease and the need for research into strategies for 
prevention and treatment.  The findings will provide current burden data to better inform 
health policy and resource allocation decisions. 
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Objectives 
 The goal of this study was to assess burden associated with osteoarthritis.  The 
specific objectives of the study were to:  
1. determine incremental annual direct health care resource utilization associated 
with osteoarthritis by categories including  hospitalizations, hospital days, 
emergency room encounters, and outpatient visits 
2. determine incremental annual direct health care expenditures associated with 
osteoarthritis by categories including total expenditures, inpatient hospital 
expenditures, emergency room expenditures, outpatient expenditures, medication 
expenditures and miscellaneous expenditures 
3. determine incremental annual number of days absent from work associated with 
osteoarthritis and 
4. determine incremental annual absenteeism costs associated with osteoarthritis  
Hypotheses 
The current study hypotheses were: 
1. presence of osteoarthritis will increase  annual direct utilization of  health care 
resources, including increase in  hospitalizations, hospital days, emergency 
room encounters, and outpatient room visits 
2. presence of osteoarthritis will increase annual direct health care expenditures, 
including increase in total expenditures, inpatient hospital expenditures, 
emergency room expenditures, outpatient expenditures, medication 
expenditures and miscellaneous expenditures 
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3. presence of osteoarthritis will increase annual absenteeism from workplace 
and  
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An observational database analysis was conducted using data from the Medical 
Expenditure Panel Survey (MEPS).   Individuals eighteen years old or older with 
osteoarthritis were compared to individuals without osteoarthritis.  A one-year study 
interval was used for analyses. 
Data Source 
Agency for Healthcare Research and Quality (AHRQ) conducts the Medical 
Expenditure Panel Survey (MEPS) nationally (Cohen, Monheit et al. 1996).  The MEPS 
survey collects information on sociodemographic characteristics, employment 
information, health conditions, and health care utilization of individuals surveyed.  
Estimates of healthcare expenditures are provided for the United States civilian 
noninstitutionalized population by the MEPS (Cohen, Monheit et al. 1996).  The MEPS 
sample design is a complex survey with disproportionate sampling where Hispanics and 
blacks are oversampled.  Sampling weights are used to adjust for the complex design of 
the survey (Cohen, Monheit et al. 1996). 
The MEPS database has two major components: the Household Component and 
the Insurance Component.  The Household Component provides data from individual 
households and their members and their medical providers. The MEPS collects data for 
each person in the household on demographic characteristics, health conditions, health 
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insurance coverage, income, and employment. The survey has many rounds of 
interviewing covering two full calendar years. The present study employed MEPS 
household component data for the year 2011.   
Study Variables 
Osteoarthritis diagnosis 
International Classification of Diseases (ICD-9-CM) system codes were used to 
identify individuals with osteoarthritis.  Individuals with ICD-9-CM code of 715 for 
osteoarthritis and allied disorders in the year 2011 were considered to be diagnosed with 
osteoarthritis (Centers for Disease Control and Prevention, 2011).  The code for 
osteoarthritis was obtained from an online 2011 ICD-9-CM and Medical Terminology 
dictionary (Centers for Medicaid and Medicare 2011).  For the analyses, osteoarthritis 
was coded as a binary variable, with ‘1’ indicating presence of the disease, and ‘0’ 
indicating absence of the disease.  Frequencies were tabulated for the osteoarthritis 
variable.   
Clinical Variables  
Charlson Comorbidity Index 
The Charlson Comorbidity Index characterizes comorbidities of patients based on 
the International Classification of Diseases (ICD) diagnosis codes (Charlson, Pompei et 
al. 1987).  Higher comorbidity scores indicate a more severe burden of comorbidity.  The 
Charlson Comorbidity Index score consists of nineteen different disease comorbidity 
categories, each allocated a weight of one to six and added to provide a total score, to 
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indicate disease burden (Charlson, Pompei et al. 1987).  A Charlson Comorbidity Index 
score of zero indicates a patient has no or minimal comorbid burden, scores between one 
and four indicate moderate burden and scores of greater than or equal to five indicate 
substantial burden (Charlson, Pompei et al. 1987).  The Charlson Comorbidity Index 
scores were created from 2011 claims from MEPS using an algorithm by Romano and 
colleagues (Romano, Roos, and Jollis 1993).  To control for potential comorbidities, 
Charlson Comorbidity Index score was included as a covariate in the analyses and coded 
as a continuous variable.  Frequencies were tabulated for the Charlson Comorbidity Index 
score.   
Hypertension 
Hypertension in the sample was identified from administrative claims with 
corresponding ICD-9-CM diagnosis code for hypertension during the one year period in 
2011.  The ICD-9-CM code for hypertension is 401 (Centers for Medicaid and Medicare 
2011).  The code for hypertension was obtained from an online 2011 ICD-9-CM and 
Medical Terminology dictionary (Centers for Medicaid and Medicare 2011).  For the 
analyses, hypertension was coded as a binary variable, with ‘1’ indicating presence of the 
disease, and ‘0’ indicating absence of the disease.  Frequencies were tabulated for the 
hypertension variable.   
Hyperlipidemia 
Hyperlipidemia in the sample was identified from administrative claims with 
corresponding ICD-9-CM diagnosis code for hyperlipidemia during the one year period 
in 2011.  The ICD-9-CM code for hypertension is 272 (Centers for Medicaid and 
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Medicare 2011).  The code for hyperlipidemia was obtained from an online 2011 ICD-9-
CM and Medical Terminology dictionary (Centers for Medicaid and Medicare 2011).  
For the analyses, hyperlipidemia was coded as a binary variable, with ‘1’ indicating 
presence of the disease, and ‘0’ indicating absence of the disease.  Frequencies were 
tabulated for the hyperlipidemia variable.   
Asthma 
Asthma in the sample was identified from administrative claims with 
corresponding ICD-9-CM diagnosis code for asthma during the one year period in 2011. 
The ICD-9-CM code for hypertension is 493 (Centers for Medicaid and Medicare 2011). 
The code for asthma was obtained from an online 2011 ICD-9-CM and Medical 
Terminology dictionary (Centers for Medicaid and Medicare 2011).  For the analyses, 
asthma was coded as a binary variable, with ‘1’ indicating presence of the disease, and 
‘0’ indicating absence of the disease.  Frequencies were tabulated for the asthma variable.   
Anxiety 
Anxiety in the sample was identified from administrative claims with 
corresponding ICD-9-CM diagnosis code for anxiety during the one year period in 2011. 
The ICD-9-CM code for hypertension is 300 (Centers for Medicaid and Medicare 2011).  
The code for anxiety was obtained from an online 2011 ICD-9-CM and Medical 
Terminology dictionary (Centers for Medicaid and Medicare 2011).  For the analyses, 
anxiety was coded as a binary variable, with ‘1’ indicating presence of the disease, and 
‘0’ indicating absence of the disease. Frequencies were tabulated for the anxiety variable.   
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Days missed at workplace 
To determine absenteeism, the MEPS survey in 2011 asked individuals to report 
number of work days lost because of illness or injury.  Days missed at work annually due 
to illness or injury in the year 2011 was coded as a count variable.   
Sociodemographic variables 
 Sociodemographic variables included age, gender, degree, race, region, marital 
status, and health insurance type.  Age of individuals in January of 2011, was coded as a 
continuous variable for the analyses.  Gender was coded in this study as “0” for males 
and “1” for females.  Race was coded as a categorical variable including “1” for White, 
“2” for Black, “3” for others.  Region was coded as a categorical variable including “1” 
for Northeast, “2” for Midwest, “3” for South, and “4” for West.   Marital status 
categories using data of individuals in January of 2011 included  “1” for married, “2” for 
widowed,  “3” for separated, “4” for divorced and “5” for never married. 
Highest degree obtained by an individual in year 2011 was coded as “1” for no 
degree, “2” for general education degree (GED), “3” for high school diploma, “4” for 
bachelor’s degree, “5” for master’s degree or doctorate degree and “6” for other degree. 
  Health insurance status was coded as a categorical variable with three categories, 
“1” as private insurance, and “2” as public insurance and “3” for no insurance.  
Frequencies were tabulated for all the sociodemographic variables.   
Wage variable 
 Individuals were asked to report their annual wage in MEPS for 2011.  Based on 
a report by Bureau of Labor Statistics, number of working days annually is calculated by 
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considering there are five working days per week, excluding federal holidays (Bureau of 
Labor Statistics 2011).  For the purposes of the current study, number of working days in 
2011 was calculated by excluding federal holidays and weekends, obtaining 250 days.  
Annual wages were divided by number of working days in 2011 to obtain daily wages.  
Daily wage was coded as a continuous variable.  Daily wage was multiplied with annual 
days missed at the workplace to obtain annual absenteeism costs.   
Healthcare utilization variables 
   Health care resource utilization among persons with osteoarthritis was estimated 
from individuals’ claims during 2011 for hospitalizations, hospital days, outpatient visits, 
and emergency room visits.  One visit at an outpatient facility was defined as a 
summation of all visits to that facility per day.  For example, if a patient visited an 
outpatient office two times in one day the resultant visit count for that day was one 
outpatient visit.  Similarly, for an emergency room visit if a patient visited an emergency 
room once on a particular day, the resultant visit count for emergency room was one. 
Hospitalizations were determined by identifying and counting the number of 
unique confinements per patient.  One admittance to the hospital for a person was 
considered as one hospitalization for the person.  Number of hospital days spent by each 
patient were identified by subtracting the patient’s admit date and discharge date at the 
hospital for each visit.   
Healthcare expenditures  
Health care resource expenditures among persons with osteoarthritis was 
estimated from individuals’ claims during 2011.   For inpatient expenditures, standard 
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cost of the inpatient admission was added to professional fees associated with the 
confinement.  Total hospitalization costs per patient were calculated by adding 
expenditures from all hospital episodes.  If there were multiple visits to the same facility 
on the same day, a visit-level summation of expenditures was generated to obtain one 
record per visit (outpatient facility or emergency room) per day.  Total annual emergency 
room expenditures and total annual outpatient expenditures per patient were calculated by 
adding facility-specific expenditures for the patient in the specified one-year period.  
Total annual prescription expenditures per patient, were calculated by adding standard 
prices for all medication claims during the specified one year period.  Total 
miscellaneous expenditures were calculated per person by adding all costs not included in 
any other resource category during the specified one year period. 
Ethical Considerations 
Application for human subjects research was approved by the Institutional 
Review Board at Purdue University, West Lafayette, Indiana.  Research proceeded upon 
approval. 
Study Sample 
Sample Inclusion Criteria 
Osteoarthritis cohort sample  
Osteoarthritis cohort included all employed people eighteen years old or older 
using claims data from 2011.  ICD-9-CM codes were used to identify employees with 
osteoarthritis: 715 for osteoarthritis and other allied disorders. 
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Comparison sample  
 Osteoarthritis cohort was compared to a comparison cohort consisting of all 
employed individuals in year 2011, eighteen years old or older and employed, but with no 
diagnosis of osteoarthritis.  
Sample Exclusion Criteria 
Individuals missing any information on age, sex, race, region, marital status, 
insurance were excluded.  Individuals missing any information on number of days missed 
at work in 2011 were excluded.  Individuals who had missing information for their wages 
in MEPS were excluded.   
Statistical Analysis 
SAS for UNIX version 9.3 (SAS Institute, 2001 Cary, NC) and STATA for UNIX 
version 12 was used for analyses.  An a priori alpha level of 0.05 was used for all 
analyses.   Frequency distributions were developed and Chi-square tests were used to 
assess statistical differences between persons with or without osteoarthritis on age, 
gender, geographical region, marital status, race, insurance status, hypertension, 
hyperlipidemia, anxiety, asthma, and Charlson Comorbidity Index.    
All-cause Health Care Resource Utilization 
All-cause Hospitalization  
All-cause hospitalizations were determined for the year 2011.  Unadjusted means 
and 95 percent confidence intervals were computed.   Residuals were not normally 
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distributed and Wilcoxon Mann Whitney tests were used to detect differences between 
individuals with osteoarthritis and those without osteoarthritis. 
All-cause Hospital days  
All-cause hospital days were determined for the year 2011.  Unadjusted means 
and 95 percent confidence intervals were computed.   Residuals were not normally 
distributed and Wilcoxon Mann Whitney tests were used to detect differences between 
individuals with osteoarthritis and those without osteoarthritis. 
All-cause Outpatient visits  
All-cause outpatient visits were determined for the year 2011.  Unadjusted means 
and 95 percent confidence intervals were computed.  Residuals were not normally 
distributed and Wilcoxon Mann Whitney tests were used to detect differences between 
individuals with osteoarthritis and those without osteoarthritis.  
All-cause Emergency room visits  
All-cause emergency room visits were determined for the year 2011.  Unadjusted 
means and 95 percent confidence intervals were computed.   Residuals were not normally 
distributed and Wilcoxon Mann Whitney tests were used to detect differences between 
individuals with osteoarthritis and those without osteoarthritis.  
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All-Cause Health Care Expenditures 
All-cause Inpatient expenditures  
All-cause inpatient expenditures were determined for the year 2011.  Unadjusted 
means and 95 percent confidence intervals were computed.   Residuals were not normally 
distributed and Wilcoxon Mann Whitney tests were used to detect differences between 
individuals with osteoarthritis and those without osteoarthritis.  
All-cause Outpatient expenditures  
All-cause outpatient expenditures were determined for the year 2011.  Unadjusted 
means and 95 percent confidence intervals were computed.  Residuals were not normally 
distributed and Wilcoxon Mann Whitney tests were used to detect differences between 
individuals with osteoarthritis and those without osteoarthritis.  
All-cause Emergency room expenditures  
All-cause emergency room expenditures were determined for the year 2011.  
Unadjusted means and 95 percent confidence intervals were computed.  Residuals were 
not normally distributed and Wilcoxon Mann Whitney tests were used to detect 
differences between individuals with osteoarthritis and those without osteoarthritis.  
All-cause Medication expenditures  
All-cause medication expenditures were determined for the year 2011.  
Unadjusted means and 95 percent confidence intervals were computed.   Residuals were 
not normally distributed and Wilcoxon Mann Whitney tests were used to detect 
differences between individuals with osteoarthritis and those without osteoarthritis.  
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All-cause Miscellaneous expenditures  
All-cause miscellaneous expenditures were determined for the year 2011.  
Unadjusted means and 95 percent confidence intervals were computed.  Residuals were 
not normally distributed and Wilcoxon Mann Whitney tests were used to detect 
differences between individuals with osteoarthritis and those without osteoarthritis.  
All-cause Total expenditures  
All-cause total expenditures were determined for the year 2011.  Unadjusted 
means and 95 percent confidence intervals were computed.  Residuals were not normally 
distributed and Wilcoxon Mann Whitney tests were used to detect differences between 
individuals with osteoarthritis and those without osteoarthritis.  
Incremental Direct Resource utilization associated with Osteoarthritis 
Based on examination of data distributional characteristics and assessment of fit 
of alternative models, a multivariate model for analysis was selected.  Direct resource 
utilization variables were count variables with discrete values.  When a count variable is 
used in an ordinary least square regression analysis as a dependent variable, violations of 
assumptions to ordinary least square regression can occur (Gardner, Mulvey, and Shaw 
1995; Coxe et al. 2009).  Residuals of ordinary least squares regression models with 
untransformed dependent variables were examined for violation of assumptions.  P values 
lower than 0.05 for each Kolmogorov-Smirnov test were used to assess whether residuals 
were normally distributed (D'Agostino and Stephens 1986).   Residuals were observed to 
be non-normal, a violation of assumption of ordinary least square regression.   
Generalized linear models using maximum likelihood method, as opposed to ordinary 
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least squares regression, were then developed and tested for model fit.   Presence of over 
dispersion of dependent variables was assessed using Vuong tests (Long and Freese 
2006; Vuong 1989), and likelihood ratio tests (Long and Freese 2006; Vuong 1989; 
Cameron and Trivedi 1986).  Zero inflated negative binomial models are employed if 
Vuong test statistics are significant at probability less than 0.05 (Vuong 1989).  The 
incremental or marginal effect of independent variables is then computed by estimating 
the expected change in the dependent variable, holding all other independent variables 
constant at their mean values. 
Incremental Inpatient Hospitalization associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and annual inpatient hospitalizations.  Response variable was 
annual inpatient hospitalization, which was a count variable.  There was presence of over 
dispersion where the variance was larger than the mean in the response variable.  Vuong 
test statistics were significant at probability less than 0.05 indicating the zero-inflated 
negative binomial model was required for analysis (Vuong 1989).  A binary predictor 
variable for osteoarthritis was included in each model and the covariates included age, 
gender, degree, race, region, marital status, health insurance type and comorbid 
conditions including hypertension, hyperlipidemia, anxiety, asthma and Charlson 
Comorbidity Index score.  The general regression model developed for estimating 
incremental hospitalization is shown below:  
Inpatient hospitalization annually =α0 + α1 osteoarthritis + covariates 
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The incremental annual hospitalization associated with osteoarthritis is the 
estimate of the parameter α1, which is the marginal effect of the independent variable 
“osteoarthritis.” 
Incremental Hospital days associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and annual hospital days.  Response variable was annual hospital 
days which was a count variable.  There was presence of over dispersion where the 
variance was larger than the mean in the response variable.  Vuong test statistics were 
significant at probability less than 0.05 indicating the zero-inflated negative binomial 
model was required for analysis (Vuong 1989).  A binary predictor variable for 
osteoarthritis was included in each model and the covariates included age, gender, 
degree, race, region, marital status, health insurance type and comorbid conditions 
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index 
score.  The general regression model developed for estimating incremental hospital days 
is shown below:  
Hospital days annually = α0 + α1 osteoarthritis + covariates 
The incremental annual hospital days associated with osteoarthritis is the estimate 
of the parameter α1, which is the marginal effect of the independent variable 
“osteoarthritis” 
Incremental Outpatient Visits associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and annual outpatient visits.  Response variable was annual 
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outpatient visit which was a count variable.  There was presence of over dispersion where 
the variance was larger than the mean in the response variable.  Vuong test statistics were 
significant at probability less than 0.05 indicating the zero-inflated negative binomial 
model was required for analysis.  A binary predictor variable for osteoarthritis was 
included in each model and the covariates included age, gender, degree, race, region, 
marital status, health insurance type and comorbid conditions including hypertension, 
hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index score.  The general 
regression model developed for estimating incremental outpatient utilization is shown 
below:  
Outpatient visits annually = α0 + α1 osteoarthritis + covariates 
The incremental annual outpatient visits associated with osteoarthritis is the 
estimate of the parameter α1, which is the marginal effect of the independent variable 
“osteoarthritis” 
Incremental Emergency Room visits associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and emergency room visits.  Response variable was annual 
emergency room visit which was a count variable.  There was presence of over dispersion 
where the variance was larger than the mean in the response variable.  Vuong test 
statistics were significant at probability less than 0.05 indicating the zero-inflated 
negative binomial model was required for analysis.  A binary predictor variable for 
osteoarthritis was included in each model and the covariates included age, gender, 
degree, race, region, marital status, health insurance type and comorbid conditions 
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index 
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score.  The regression model developed for estimating incremental emergency room 
utilization is shown below:  
Emergency room visits annually= α0 + α1 osteoarthritis + covariates 
The incremental annual emergency room visits associated with osteoarthritis is 
the estimate of the parameter α1, which is the marginal effect of the independent variable 
“osteoarthritis.” 
Incremental Direct Resource Expenditures associated with Osteoarthritis 
Based on examination of data distributional characteristics and assessment of fit 
of alternative models, a multivariate model for analysis was selected.  Direct resource 
expenditures variables are count variables with discrete values.  When a count variable is 
used in an ordinary least square regression analysis as a dependent variable, violations of 
assumptions to ordinary least square regression can occur (Gardner, Mulvey, and Shaw 
1995; Coxe et al. 2009).  Residuals of ordinary least squares regression models with 
untransformed dependent variables were examined for violation of assumptions.  P values 
lower than 0.05 for each Kolmogorov-Smirnov test were used to assess whether residuals 
were normally distributed (D'Agostino and Stephens 1986).  Residuals were observed to 
be not normal and a violation of assumption of ordinary least square regression.   
Generalized linear models using maximum likelihood method, as opposed to ordinary 
least squares regression, were then developed and tested for model fit.   Presence of over 
dispersion of dependent variables was assessed using Vuong tests (Long and Freese 
2006; Vuong 1989), and likelihood ratio tests (Long and Freese 2006; Vuong 1989; 
Cameron and Trivedi 1986).  Zero inflated negative binomial models are employed if 
Vuong test statistics are significant at probability less than 0.05 (Vuong 1989).  The 
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incremental or marginal effect of independent variables is then computed by estimating 
the expected change in the dependent variable, holding all other independent variables 
constant at their mean values. 
Incremental Inpatient Expenditures associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and inpatient expenditures.  Response variable was annual 
inpatient expenditures which was a count variable.  There was presence of over 
dispersion where the variance was larger than the mean in the response variable.  Vuong 
test statistics were significant at probability less than 0.05 indicating the zero-inflated 
negative binomial model was required for analysis.  A binary predictor variable for 
osteoarthritis was included in each model and the covariates included age, gender, 
degree, race, region, marital status, health insurance type and comorbid conditions 
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index 
score.  The regression model developed for estimating incremental inpatient expenditures 
is shown below:  
Annual inpatient expenditures = α0 + α1 osteoarthritis + covariates 
The incremental inpatient expenditures associated with osteoarthritis is the 
estimate of the parameter α1, which is the marginal effect of the independent variable 
“osteoarthritis.” 
Incremental Outpatient Expenditures associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and outpatient expenditures.  Response variable was annual 
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outpatient expenditures which was a count variable.  There was presence of over 
dispersion where the variance was larger than the mean in the response variable.  Vuong 
test statistics were significant at probability less than 0.05 indicating the zero-inflated 
negative binomial model was required for analysis.  A binary predictor variable for 
osteoarthritis was included in each model and the covariates included age, gender, 
degree, race, region, marital status, health insurance type and comorbid conditions 
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index 
score.  The regression model developed for estimating incremental outpatient 
expenditures is shown below:  
Annual outpatient expenditures= α0 + α1 osteoarthritis + covariates 
The incremental annual outpatient expenditures associated with osteoarthritis is 
the estimate of the parameter α1, which is the marginal effect of the independent variable 
“osteoarthritis.” 
Incremental Emergency Room Expenditures associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and emergency room expenditures.  Response variable was annual 
emergency room expenditures which was a count variable.  There was presence of over 
dispersion where the variance was larger than the mean in the response variable.  Vuong 
test statistics were significant at probability less than 0.05 indicating the zero-inflated 
negative binomial model was required for analysis.  A binary predictor variable for 
osteoarthritis was included in each model and the covariates included age, gender, 
degree, race, region, marital status, health insurance type and comorbid conditions 
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index 
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score.  The regression model developed for estimating incremental emergency room 
expenditures is shown below:  
Annual emergency room expenditure= α0 + α1 osteoarthritis + covariates 
The incremental annual emergency room expenditures associated with 
osteoarthritis is the estimate of the parameter α1, which is the marginal effect of the 
independent variable “osteoarthritis.” 
Incremental Medication Expenditures associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and medication expenditures.  Response variable was annual 
medication expenditures which was a count variable.  There was presence of over 
dispersion where the variance was larger than the mean in the response variable.  Vuong 
test statistics were significant at probability less than 0.05 indicating the zero-inflated 
negative binomial model was required for analysis.  A binary predictor variable for 
osteoarthritis was included in each model and the covariates included age, gender, 
degree, race, region, marital status, health insurance type and comorbid conditions 
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index 
score.  The regression model developed for estimating incremental medication 
expenditures is shown below:  
Annual medication expenditures= α0 + α1 osteoarthritis + covariates 
The incremental annual medication expenditures associated with osteoarthritis is 
the estimate of the parameter α1, which is the marginal effect of the independent variable 
“osteoarthritis.” 
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Incremental Miscellaneous Expenditures associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and miscellaneous expenditures or expenditures not included in 
any other category.   Response variable was annual miscellaneous expenditures which 
was a count variable.  There was presence of over dispersion where the variance was 
larger than the mean in the response variable.  Vuong test statistics were significant at 
probability less than 0.05 indicating the zero-inflated negative binomial model was 
required for analysis.  A binary predictor variable for osteoarthritis was included in each 
model and the covariates included age, gender, degree, race, region, marital status, health 
insurance type and comorbid conditions including hypertension, hyperlipidemia, anxiety, 
asthma and Charlson Comorbidity Index score.  The regression model developed for 
estimating incremental annual miscellaneous expenditures is shown below:  
Annual miscellaneous expenditures= α0 + α1 osteoarthritis + covariates 
The incremental annual miscellaneous expenditures associated with osteoarthritis 
is the estimate of the parameter α1, which is the marginal effect of the independent 
variable “osteoarthritis.” 
Incremental Total Expenditures associated with Osteoarthritis 
A generalized linear model was developed to estimate independent association 
between osteoarthritis and total expenditures.  Response variable was total expenditures 
which was a count variable.  There was presence of over dispersion where the variance 
was larger than the mean in the response variable.  Vuong test statistics were significant 
at probability less than 0.05 indicating the zero-inflated negative binomial model was 
required for analysis.  A binary predictor variable for osteoarthritis was included in each 
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model and the covariates included age, gender, degree, race, region marital status, health 
insurance type and comorbid conditions including hypertension, hyperlipidemia, anxiety, 
asthma and Charlson Comorbidity Index score.   The regression model developed for 
estimating incremental annual total expenditures is shown below:  
Annual total expenditures= α0 + α1 osteoarthritis + covariates 
The incremental annual total expenditures associated with osteoarthritis is the 
estimate of the parameter α1, which is the marginal effect of the independent variable 
“osteoarthritis.” 
Incremental absenteeism associated with Osteoarthritis  
A generalized linear model was developed to estimate independent association 
between osteoarthritis and absenteeism.  Response variable was annual absenteeism 
which was a count variable.  There was presence of over dispersion where the variance 
was larger than the mean in the response variable.  Vuong test statistics were significant 
at probability less than 0.05 indicating the zero-inflated negative binomial model was 
required for analysis.  Days absent from work due to illness annually was employed as 
the response variable.  A binary variable indicating the presence or absence of 
osteoarthritis was included as predictor variable.  Covariates for the model included age, 
gender, degree, race, region, marital status, health insurance type and comorbid 
conditions including hypertension, hyperlipidemia, anxiety, and asthma as well as 
Charlson Comorbidity Index.   The general regression model developed for estimating 
incremental absenteeism is shown below:  
Days absent from work annually= α0 + α1 osteoarthritis + covariates 
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The incremental absenteeism associated with osteoarthritis is the estimate of the 
parameter α1, which is the marginal effect of the independent variable “osteoarthritis.” 
Incremental Absenteeism Expenditures associated with Osteoarthritis 
Daily wage was estimated by dividing annual wages by number of working days 
in the year.  Working days in year 2011 was assumed to be 250 days after accounting for 
holidays and weekends.  All working days lost due to health problems was multiplied 
with daily wage of an individual to obtain annual absenteeism costs (Liu et al. 2002; Krol 
and Brouwer 2014).  A generalized linear model was developed to estimate independent 
association between osteoarthritis and absenteeism costs.  Response variable was annual 
absenteeism costs which was a count variable.  There was presence of over dispersion 
where the variance was larger than the mean in the response variable.  Vuong test 
statistics were significant at probability less than 0.05 indicating the zero-inflated 
negative binomial model was required for analysis. The response variable was annual 
absenteeism costs.  Predictor variable included a binary variable indicating the presence 
or absence of osteoarthritis.  Covariates for the model included age, gender, degree, race, 
marital status, and health insurance type, and comorbid conditions for osteoarthritis 
including hypertension, hyperlipidemia, asthma, anxiety and Charlson Comorbidity Index 
scores.  The general regression model developed for estimating incremental absenteeism 
costs is shown below:  
Annual absenteeism costs = α0 + α1 osteoarthritis + covariates 
The incremental annual absenteeism costs associated with osteoarthritis is the 




Bureau of Labor Statistics, U.S. Department of Labor. 2011.  Occupational Outlook 
Handbook, [3 March, 2015] [http://www.bls.gov/news.release/pdf/wkstp.pdf]. 
Cameron, A. Colin, and Pravin K. Trivedi. 1986. Econometric Models Based on Count 
Data.Comparisons and Applications of Some Estimators and Tests. J Appl 
Econ(Chichester Engl) 1 (1): 29-53. 
Centers for Disease Control and Prevention. 2011. Classification of Diseases, 
Functioning, and Disability. Retrieved 
from http://www.cdc.gov/nchs/icd/icd9cm.htm 
Charlson, Mary E., Peter. Pompei, Kathy. L. Ales, and C. Ronald. MacKenzie.1987. A 
new method of classifying prognostic comorbidity in longitudinal studies: 
development and validation. J Chronic Dis 40(5): 373-383. 
Cohen, Joel W., Alan C. Monheit, Karen Beauregard, Steven Cohen and Doris Lefkovitz. 
1996. The Medical Expenditure Panel Survey: a national health information 
resource. Inquiry 33(4): 373-389. 
Coxe S, West SG, Aiken LS. 2009. The analysis of count data: a gentle introduction to 
poisson regression and its alternatives.  J Pers Assess. 91(2):121-36. doi: 
10.1080/00223890802634175. 
D'Agostino, Ralph .B., and Micheal .A. Stephens. 1986. Goodness-of-Fit Technicques. 
New York: Marcel Dekker. 
Krol, Marieke. and Werner Brouwer 2014. How to estimate productivity costs in 
economic evaluations. Pharmacoeconomics 32(4): 335-344. 
Long, Scott J., and Jeremy Freese. 2006. Regression Models for Categorical Dependent 
Variables Using Stata. Second ed. Thousand Oaks, CA: Stata Press. 
Romano, Patrick S., Leslie L. Roos, and James G. Jollis. 1993. Adapting a clinical 
omorbidity index for use with ICD-9-CM administrative data: differing 
perspectives. Journal of Clinical Epidemiology 46 (10): 1075-9; discussion 1081-
90. 
Vuong, Quang H. 1989. Likelihood Ratio Tests for Model Selection and Non-Nested 
Hypotheses. Econometrica 57 (2): 307-333. 
59 
RESULTS 
Sample for Analyses 
Figure 1 shows the sample selection procedure and results of selection of the 
sample for analyses.  The total number of individuals who participated in MEPS 
Household Component of the Medical Expenditure Panel Survey in 2011 were 35,313.  
After excluding 5,762 individuals who were younger than eighteen years of age, 29,551 
individuals remained.  After excluding 2,559 unemployed individuals, 26,992 remained.   
Out of 26,992 individuals, 1,354 individuals had a diagnosis of osteoarthritis.  Individuals 
with osteoarthritis were compared to individuals without osteoarthritis on age, sex, race, 
region, marital status, insurance, comorbidities including hypertension, hyperlipidemia, 
anxiety, asthma, and Charlson Comorbidity Index scores.  
Distribution of Individuals by Age 
The distribution by age for the sample used in analyses is shown in Table 1.  For 
the total sample, approximately half of the total sample were (48%) were between 18 and 
54 years of age.  Data on age were not available for 7,252 individuals.  Individuals 55 
years old or older comprised 27 percent of the total sample. 
For individuals with osteoarthritis, a majority of the sample, 1,040 individuals 
(77.12%) were 55 years or older.  However, for individuals without osteoarthritis, 6,078 






















                            Figure 1. Sample Selection for Analyses       
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Table 1. Distribution of Study Sample by Age (n=26,992) 
______________________________________________________________________  
   Individuals with Individuals without   
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
  ________________   _______________   ________________  
 Age Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       <0.001 
 18 to 34 5,633 22.10 27 2.01 5,606 21.84  
 35 to 44 3,289 12.19 78 5.82 3,211 12.52  
 45 to 54 3,327 13.69 195 14.54 3,505 13.67  
 55 to 64 3,279 12.12 389 29.04 2,890 11.27  
 65 and over 3,839 14.24 651 48.08 3,188 12.43  
 Missing 7,252 25.66 14 1.03 7,238 28.23 
______________________________________________________________________  
     1Chi-square probability between osteoarthritis and non-osteoarthritis groups 
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Distribution of Individuals by Gender 
The distribution by gender for the sample used in analyses is shown in Table 2.  
For the total sample, the proportion of females was higher (54.43%) than males 
(45.57%).  Similarly, for individuals with osteoarthritis, a majority of the sample were 
females (70%) and for individuals without osteoarthritis, 54 percent were females. 
Distribution of Individuals by Race 
 Table 3 shows the distribution of the sample by race. For the total sample, 
majority were whites (70.55%), followed by blacks (19.89%) and the rest belonged to 
other races.  Similarly, for individuals with osteoarthritis, 78 percent were whites, 
followed by blacks at 15 percent, and the rest of the cohort were from other races.  For 
individuals without osteoarthritis, 70 percent were white, 20 percent were black, and rest 
were from other races.  
Distribution of Individuals by Region 
Table 4 shows the distribution of the sample by geographical region. The sample 
was divided into four regions including the Midwest, Northeast, South and West.  Most 
individuals belonged to the south with 9,953 individuals (37.11%), followed by 
individuals from the west at 6,881 individuals (25.65%) from the west, 5,793 individuals 
(21.60%) from Midwest and 4,196 individuals (15.64%) from Northeast.  Among persons 
with osteoarthritis, a total of 500 persons (36.93%) were from the South.  The proportion 
of individuals from the comparison group without osteoarthritis from the South was 
similar at 36.87 percent.  
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Table 2. Distribution of Study Sample by Gender (n=26,992) 
______________________________________________________________________  
   Individuals with Individuals without   
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
  ________________   ______________   ________________  
 Gender Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       <0.001 
 Male  12,301 45.57 402 29.69 11,889 46.41 
 Female 14,691 54.43 952 70.31 13,739 53.59 
______________________________________________________________________  
1Chi-square probability between osteoarthritis and non-osteoarthritis groups 
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Table 3. Distribution of Study Sample by Race (n=26,992) 
______________________________________________________________________  
   Individuals with Individuals without   
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
  ________________   ______________   ________________  
 Race Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       <0.001 
 White 19,044 70.55 1,056 77.99 17,988 70.16  
 Black 5,369 19.89 207 15.29 5,162 20.13  
 Other 2,579 9.55 91 6.72 2,488 9.71 
______________________________________________________________________  




Table 4. Distribution of Study Sample by Region (n=26,992) 
______________________________________________________________________  
   Individuals with Individuals without   
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
  ________________   ______________   ________________  
 Region Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       0.003 
 Northeast 4,196       15.64      218 16.10 3,978 15.52 
 Midwest 5,793       21.60       329 24.30 5,464 21.31  
 South 9,953       37.11   500 36.93 9,453 36.87      
 West 6,881       25.65 293 21.64 6,588 25.70 
 Missing 169 0.63 14 1.03 155 0.60  
______________________________________________________________________  




Distribution of Individuals by Marital status 
Distribution of sample by marital status is shown in Table 5. For marital status, 
most of the individuals were not married (45.69%), followed by married individuals 
(37.17%), individuals who were widowed (5.5%), divorced (9.24%) and separated 
(2.39%).  Approximately half of the individuals with osteoarthritis were married, while 
47.65% of individuals without osteoarthritis were not married.  
Distribution of Individuals by Degree 
Table 6 shows the distribution of the sample by educational degree.   At least 
8,693 individuals (32 percent) of the total sample obtained a high school degree.  
Approximately 15 percent of the sample had no degree, followed by 11.5 percent who 
had a bachelor’s degree.  Only 6 percent of the total sample had a masters or doctorate 
degree.    
Similarly, for individuals with osteoarthritis, 621 (45.86%) individuals had a high 
school degree, followed by 226 individuals (16.69%) with no degree and 192 individuals 
(14.18%) with bachelor’s degree.  For individuals without osteoarthritis, proportion of 
individuals with high school degree as compared to osteoarthritis cohort was lower at 
31.48 percent. 
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Table 5. Distribution of Study Sample by Marital status (n=26,992) 
______________________________________________________________________  
   Individuals with Individuals without   
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
  ________________   ______________   ________________  
 Marital Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       <0.001 
 Married 10,034     37.17 670 49.48 9,364 36.52 
 Widowed 1,485  5.50 247  18.24    1,238 4.83      
 Divorced 2,495  9.24 274 20.24     2,221 8.66 
 Separated 646 2.39      47 3.47  599 2.34    
Never married 12,332    45.69  116 8.57   12,216 47.65 
______________________________________________________________________  
1Chi-square probability between osteoarthritis and non-osteoarthritis groups 
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Table 6. Distribution of Study Sample by highest Degree obtained (n=26,992) 
______________________________________________________________________  
   Individuals with Individuals without   
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
 _______________  ______________   _____________  
 Degree Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       <0.001 
No Degree 4,115  15.25 226 16.69 3,889 15.17 
 GED 879 3.26 80 5.91 799 3.12 
High school 8,693 32.21 621 45.86 8,072 31.48 
Bachelor 3,105 11.50 192 14.18  2,913 11.36 
Masters or Doctorate 1,642 6.08 96 7.83  1,536 6.56 
Other 8,558 31.71 129 9.53 8,429 32.87 
______________________________________________________________________  




Distribution of Individuals by Insurance 
Table 7 shows the distribution of the sample by insurance coverage.   Most of the 
sample, 15,032 individuals (55.7%) had private insurance followed by 8,472 individuals 
(31.4%) with private insurance and 3,488 individuals (13%) with no insurance.  
Similarly, for individuals with osteoarthritis, majority of the sample at 773 
individuals (57%) had public insurance, followed by 494 individuals (36.5%) who had 
private insurance, and 87 individuals (6.4%) who were uninsured.  Similar trend was 
observed for individuals without osteoarthritis where 14,259 individuals (55.6%) had 
private insurance, 7,978 individuals (31.12%) had public insurance and 3,401 individuals 
(13.27%) were uninsured.  
Distribution of Individuals by Hypertension 
The sample distribution based on presence and absence of hypertension is shown 
in Table 8.  Hypertension was present in a total of 6,504 persons (24.1%) of the overall 
sample. Among persons with osteoarthritis, 844 individuals (62.3%) had a diagnosis of 
hypertension, which was significantly higher than among persons without osteoarthritis, 
where 5,660 individuals (22.08%) had hypertension. 
Distribution of Individuals by Hyperlipidemia 
The sample distribution based on presence and absence of hyperlipidemia is 
shown in Table 8.  Hyperlipidemia was present in a total of 5,001 persons (18.5%) of the 
overall sample.  Among persons with osteoarthritis, 51 percent had a diagnosis of 
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hyperlipidemia, which was significantly higher than among persons without 
osteoarthritis, where 16.8 percent had hyperlipidemia. 
Distribution of Individuals by Anxiety 
The sample distribution based on presence and absence of anxiety is shown in 
Table 8.  Anxiety was present in a total of 1,710 persons (6.3%) of the overall sample. 
Among persons with osteoarthritis, 204 individuals (15%) had a diagnosis of anxiety, 
which was significantly higher than among persons without osteoarthritis, where 1,506 
individuals (5.9%) had anxiety. 
Distribution of Individuals by Asthma 
The sample distribution based on presence and absence of asthma is shown in 
Table 8.  Asthma was present in a total of 2,267 persons (8.4%) of the overall sample.  
Among persons with osteoarthritis, 14 percent had a diagnosis of asthma, which was 
significantly higher than among persons without osteoarthritis, where 8 percent had 
asthma. 
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Table 7. Distribution of Study Sample by Insurance Coverage  
______________________________________________________________________  
   Individuals with Individuals without  
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
  ________________   ______________   _______________  
 Insurance Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       <0.001 
 Private 15,032       55.69  773 57.09 14,259 55.62  
 Public 8,472       31.39   494  36.48     7,978 31.12  
 Uninsured 3,488       12.92   87  6.43  3,401 13.27 
______________________________________________________________________  
 1Chi-square probability between osteoarthritis and non-osteoarthritis groups 
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Table 8. Distribution of Study Sample by Comorbid Disease conditions  
______________________________________________________________________  
   Individuals with Individuals without  
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
 ______________   ______________   _______________  
Comorbidities Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       <0.001 
Hypertension  6,504 24.10  844 62.33 5,660 22.08 
No hypertension  20,488 75.90 510 37.67 19,978 77.92  
       <0.001 
Hyperlipidemia  5,001 18.53 691 51.03 4,310 16.81        
No hyperlipidemia 21,991 81.47 663 48.97 21,328  83.19     
       <0.001 
Anxiety 1,710 6.34 204 15.07 1,506 5.87  
Non Anxiety 25,282 93.66 1,150 84.93 24,132 94.13 
       <0.001 
Asthma 2,267 8.40 192 14.18 2,075 8.09  
Non Asthma 24,725 91.60 1,162 85.82 23,563 91.91   
______________________________________________________________________  
1Chi-square probability between osteoarthritis and non-osteoarthritis groups 
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Distribution of Individuals by Charlson Comorbidity Index score 
Table 9 describes the distribution of the study sample and compares persons with 
osteoarthritis and those without osteoarthritis with respect to Charlson Comorbidity Index 
scores.  Seventy-four percent of the sample had a Charlson comorbidity score of zero 
indicating that they did not have any of the comorbid conditions listed in the Charlson 
Comorbidity Index.  Approximately, 19 percent of the sample had a score of one and 4 
percent of the sample had a score of two.  Among individuals with osteoarthritis, 50 
percent had a Charlson comorbidity score of zero indicating that they did not have any of 
the comorbid conditions listed in the Charlson Comorbidity Index.  Individuals with 
osteoarthritis and with a score of one on the Charlson Comorbidity Index comprised 
30.43 percent of the sample, and 10.19 percent of the group with osteoarthritis had a 
score of two. Similarly, among individuals without osteoarthritis, 75.46 percent had a 
Charlson comorbidity score of zero.  Individuals without osteoarthritis and with a score 
of one on the Charlson Comorbidity Index comprised 18.26 percent of the sample.  
Distribution of Individuals by Annual Wages 
Table 10 shows the distribution of the sample by annual wages.   Most of the 
sample, 13,733 individuals (50.8%) reported zero wages, followed by 10,349 individuals 
(38.7%) who reported annual wages between 0 and 50,000 dollars.  For individuals with 
osteoarthritis, 793 individuals (58.57%) reported annual wages of zero, followed by 441 
individuals (32.57%) with annual wages between 0 and 50,000 dollars.  Similarly for 
individuals without osteoarthritis, 50.5 percent reported annual wages of zero and 38.9 
reported annual wages between 0 and 50,000 dollars.
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Table 9. Distribution of Study Sample by Charlson Comorbidity Index score 
______________________________________________________________________  
   Individuals with Individuals without  
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
  ________________   ______________   ______________  
Charlson 
Comorbidity 
Index score Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       <0.001 
 0 20,024        74.18        678 50.07 19,346 75.46  
 1 5,094        18.87   412 30.43      4,682 18.26  
 2 1,194         4.42 138 10.19  1,056 4.12   
 3 390         1.44       74 5.47 316 1.23  
 4 118         0.44       28 2.07 90 0.35  
 5 24         0.09       3 0.22 21 0.08  
6 or greater 148         0.55  21 1.55 127 0.50        
____________________________________________________________________  








Table 10. Distribution of Study Sample by Annual Wages 
______________________________________________________________________  
   Individuals with Individuals without  
  Total sample osteoarthritis osteoarthritis 
  (N=26,992) (N=1,354) (N=25,638)  
  _________________  _____________   _______________  
Annual wages Number Percent Number Percent Number Percent Prob.1 
______________________________________________________________________  
       0.982 
 0 13,733 50.87       793 58.57 12,940 50.47  
1 to 50,000 10,439 38.67   441 32.57 9,998 38.99  
50,001 to 100,000 2,262         8.38 90  6.64 2,172 8.47   
100,001 to 200,000 514        1.90       28 2.06 486 1.89  
200,001 to 300,000    44 0.16 2 0.14 42 0.16 
____________________________________________________________________  
  1Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Unadjusted Annual Health Care Resource Utilization 
Mean unadjusted annual health care utilization for persons with or without 
osteoarthritis is reported in Table 11.  Mean annual unadjusted hospitalizations among 
individuals with osteoarthritis were 0.24 (95 percent confidence interval: 0.21 to 0.26).  
Unadjusted hospital days among individuals with osteoarthritis were 5.45 (95 percent 
confidence interval: 3.95 to 6.95).  Mean annual unadjusted outpatient visits among 
individuals with osteoarthritis were 12.93 (95 percent confidence interval: 12.11 to 
13.76).  Mean annual unadjusted emergency room visits among individuals with 
osteoarthritis were 0.33 (95 percent confidence interval: 0.29 to 0.38).    
Compared to individuals with osteoarthritis, significantly lower mean unadjusted 
hospitalizations, mean unadjusted outpatient room visits and mean unadjusted emergency 
room visits were observed among those without osteoarthritis.  Mean annual unadjusted 
hospitalizations among individuals without osteoarthritis were 0.09 (95 percent 
confidence interval: 0.09 to 0.10, P-value <0.001).  Mean annual unadjusted outpatient 
visits among individuals without osteoarthritis were 4.89 (95 percent confidence interval: 
4.76 to 5.01, P-value <0.001).   Mean annual unadjusted emergency room visits among 
individuals without osteoarthritis were 0.22 (95 percent confidence interval: 0.21 to 0.23, 
P-value <0.001).  No significant difference in the mean unadjusted hospital days were 
observed between persons with osteoarthritis and those without osteoarthritis.  Mean 
annual unadjusted hospital days among individuals without osteoarthritis were 5.18 (95 
percent confidence interval: 4.74 to 5.63, p value=0.532). 
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Table 11. Unadjusted Annual Health Care utilization among Individuals with Osteoarthritis and Individuals without Osteoarthritis 
____________________________________________________________________________________________________________ 
 With Osteoarthritis Without Osteoarthritis 
 (n=1,354) (n = 25,638) 
  ________________________________   ____________________________  
Health Care 
Utilization Category Mean 95% Confidence Interval Mean 95% Confidence Interval Prob.1  
____________________________________________________________________________________________________________ 
 Hospitalization 0.24 0.21 to 0.27 0.09 0.09 to 0.10 <0.001 
 Hospital days 5.45 3.95 to 6.95 5.18 4.74 to 5.63 0.532  
Outpatient visits 12.93 12.11 to 13.76 4.89 4.76 to 5.01 <0.001 
Emergency room visits 0.33 0.29 to 0.38 0.22 0.21 to 0.23 <0.001 
__________________________________________________________________________________________________________  










Unadjusted Annual Health Care Resource Expenditures 
Mean unadjusted annual health care expenditures for persons with or without 
osteoarthritis is reported in Table 12.  Mean annual unadjusted inpatient expenditures 
among individuals with osteoarthritis were $3,563.40 (95 percent confidence interval: 
$2,584.90 to $4,541.90).  Mean annual unadjusted outpatient expenditures among 
individuals with osteoarthritis were $3,242.11 (95 percent confidence interval: $2,922.83 
to $3,561.40).  Mean annual unadjusted emergency room expenditures among individuals 
with osteoarthritis were $295.14 (95 percent confidence interval: $234.20 to $356.08).  
Mean annual unadjusted medication expenditures among individuals with osteoarthritis 
were $2,366.36 (95 percent confidence interval: $2,137.37 to $2,595.34).  Mean annual 
unadjusted total expenditures among individuals with osteoarthritis were $ 9,651.50 (95 
percent confidence interval: 8,521.18 to 10,781.81).   
Compared to individuals with osteoarthritis, significantly lower mean unadjusted 
inpatient expenditures, mean unadjusted outpatient expenditures, mean unadjusted 
emergency room expenditures, and mean unadjusted medication expenditures and mean 
unadjusted total expenditure were observed among those without osteoarthritis. Mean 
annual unadjusted inpatient expenditures among individuals without osteoarthritis were 
$1,191.64 (95 percent confidence interval: 1,093.91 to 1,289.38, P-value <0.001).  Mean 
annual unadjusted outpatient expenditures among individuals without osteoarthritis were 
$1,223.09 (95 percent confidence interval: 1,172.04 to 1,274.14, P-value <0.001).   Mean 
annual emergency room expenditures among individuals without osteoarthritis were 
$186.98 (95 percent confidence interval: $175.30 to $198.66, P-value <0.001).  
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Table 12. Unadjusted Annual Health Care Expenditures in Dollars among Individuals with Osteoarthritis and Individuals without 
Osteoarthritis 
____________________________________________________________________________________________________________ 
 With Osteoarthritis Without Osteoarthritis 
 (n=1,354) (n = 25,638) 
  _________________________________   ____________________________  
Health Care 
expenditure Category Mean 95% Confidence Interval Mean 95% Confidence Interval Prob.1  
____________________________________________________________________________________________________________ 
Inpatient expenditures 3,563.40 2,584.90 to 4,541.90 1,191.64 1,093.91 to 1,289.38  <0.001 
Outpatient expenditures 3,242.11 2,922.83 to 3,561.40 1,223.09 1,172.04 to 1,274.14 <0.001 
Emergency room expenditures 295.14 234.20 to 356.08  186.98 175.30 to 198.66 <0.001 
Medication expenditures 2,366.36 2,137.37 to 2,595.34 962.28 786.47 to 1,138.10 <0.001 
Miscellaneous expenditures 184.48 143.70 to 225.26 66.90 61.83 to 71.96 <0.001 
Total expenditures 9,651.50 8,521.18 to 10,781.81 3,630.91 3415.49 to 3,846.34 <0.001 
__________________________________________________________________________________________________________  











Unadjusted Annual Absenteeism  
Mean unadjusted absenteeism for persons with or without osteoarthritis is 
reported in Table 13.  Mean annual unadjusted absenteeism among individuals with 
osteoarthritis was 8.72 days (95 percent confidence interval: 6.69 to 10.76).  Mean annual 
unadjusted absenteeism among individuals without osteoarthritis was significantly lower 
than individuals with osteoarthritis (p<0.001).  Mean annual unadjusted absenteeism for 
individuals without osteoarthritis was 4.95 days (95 percent confidence interval: 4.65 to 
5.25).   
 Unadjusted Annual Absenteeism costs  
Mean unadjusted absenteeism costs for individuals with or without osteoarthritis 
is reported in Table 14.  Mean annual unadjusted absenteeism costs among individuals 
with osteoarthritis was $1,393.26 (95 percent confidence interval: $814.91 to $1,971.62).  
Mean annual unadjusted absenteeism costs among individuals without osteoarthritis was 
significantly lower than individuals with osteoarthritis (p<0.001).  Mean annual 
unadjusted absenteeism costs for individuals without osteoarthritis were $650.16 (95 
percent confidence interval: $601.18 to $699.14). 
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Table 13. Unadjusted Annual Absenteeism among Individuals with Osteoarthritis and Individuals without Osteoarthritis 
____________________________________________________________________________________________________________ 
 With Osteoarthritis Without Osteoarthritis 
 (n=1,354) (n = 25,638) 
  _____________________________   ____________________________  
Category Mean 95% Confidence Interval Mean 95% Confidence Interval Prob.1  
____________________________________________________________________________________________________________ 
Absenteeism  8.72 6.69 to 10.76 4.95 4.65 to 5.25 <0.001 
__________________________________________________________________________________________________________  
 1Wilcoxon two-sample probability between osteoarthritis and non-osteoarthritis groups 
 







Table 14. Unadjusted Annual Absenteeism costs in dollars among persons with Osteoarthritis and those without Osteoarthritis 
____________________________________________________________________________________________________________ 
 With Osteoarthritis Without Osteoarthritis 
 (n=1,354) (n = 25,638) 
  ________________________________   ____________________________  
Category Mean 95% Confidence Interval Mean 95% Confidence Interval Prob.1  
____________________________________________________________________________________________________________ 
Absenteeism costs 1393.26 814.91 to 1971.62 650.16 601.18 to 699.14 <0.001 
__________________________________________________________________________________________________________  









Association between Osteoarthritis and Incremental Annual Hospitalization  
Utilization of healthcare resources, health care expenditures, absenteeism and 
absenteeism costs in this study had a high number of observations with zeros.  Over 
dispersion of each resource utilization variable and expenditure variable evidenced by p-
values less than 0.05 for Vuong tests, suggested a need for a zero-inflated generalized 
linear model (Long and Freese 2006; Vuong 1989).   Significant likelihood ratio tests, 
shown by p-values less than 0.05 indicated that for each dependent variable, zero-inflated 
negative binomial models were more suitable than zero-inflated Poisson models (Long 
and Freese 2006; Vuong 1989; Cameron and Trivedi 1986).  
Zero-inflated negative binomial models were constructed for each of the statistical 
models.  Results of incremental utilization of hospitalization associated with 
osteoarthritis is reported in Table 15.  Annual mean incremental hospitalizations 
associated with osteoarthritis was significant at 0.07 hospitalizations (p<0.001).  There 
were no significant differences in mean annual hospitalization between males and 
females (p=0.072).  Individuals who belonged to other races, exclusive of blacks, had 
significantly lower mean annual hospitalizations than whites (0.03 visits, p=0.015).  
Individuals who had public insurance had higher mean annual hospitalizations as 
compared to individuals with private insurance (0.07 visits, p<0.001).  Individuals who 
were uninsured had lower mean annual hospitalization utilization as compared to 
individuals with private insurance (0.04 visits, p<0.001).  Among comorbid conditions, 
individuals with hypertension showed significant higher mean annual hospitalization as 
compared to individuals without hypertension (0.04 visits, p=0.001).   
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Table 15.  Association between Osteoarthritis and Annual Incremental utilization of 
Hospitalizations (n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 0.07 0.01 <0.001  
 Region 
Northeast Reference    
Midwest 0.001 0.01 0.848 
South 0.002 0.01 0.844  
 West -0.001 0.01 0.870  
Age  -0.001 0.01 0.331  
Sex  
Male Reference 
Female 0.01 0.01 0.072  
 Race 
White Reference 
Black 0.01 0.01 0.380 
Other -0.03 0.01 0.015  
Marital Status 
Married Reference 
Widowed 0.02 0.02 0.384  
Divorced -0.01 0.01 0.624  
Separated -0.05 0.01 0.012  
Never married -0.03 0.01 0.003  
Degree 
No degree Reference 
GED 0.01 0.02 0.546  
High School Diploma -0.001 0.01 0.515  
Bachelor’s degree -0.01 0.01 0.021  
Masters or Doctorate -0.01 0.02 0.161  
Other degree -0.04 0.01 0.038  
Insurance coverage 
Private Reference 
Public 0.07 0.01 <0.001  
Uninsured -0.04 0.01 <0.001  
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Table 15. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension  
No hypertension Reference 
Has hypertension 0.04 0.01 0.001  
Hyperlipidemia 
No hyperlipidemia Reference 
 Has hyperlipidemia -0.001 0.01 0.566  
Anxiety 
No Anxiety Reference 
Has Anxiety 0.04 0.01 0.005  
Asthma  
No asthma Reference 
Has asthma -0.001 0.01 0.682 
Charlson Comorbidity Index 0.05 0.003 <0.001  
________________________________________________________________________ 
 Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 








Association between Osteoarthritis and Incremental Annual Hospital days  
Results of incremental hospital days associated with osteoarthritis is reported in 
Table 16.  Hospital days spent was not incrementally greater for individuals with 
osteoarthritis (0.06 days, p=0.287).  There was no significant difference in annual mean 
days spent at hospital between females and males (p=0.447).  Black individuals had 
significantly higher mean annual hospital days than whites (0.10 days, p=0.032).    
Individuals who were never married spent fewer days at hospital compared to individuals 
who were married (0.09 days, p=0.045).  Individuals who had public insurance had 
greater mean annual hospital days as compared to individuals with private insurance 
(0.34 days, p<0.001).   
Among comorbid conditions, individuals with hypertension spent more days at 
hospital as compared to individuals without hypertension (0.13 hospital days, p=0.006).   
Individuals with hypertension spent more days at hospital as compared to individuals 
without hypertension (0.13 hospital days, p=0.006).  There were no significant 
differences observed in annual mean hospital days spent between individuals who had 
hyperlipidemia and those who did not have hyperlipidemia.  Similarly, there were no 
significant differences observed in annual mean hospital days spent between individuals 
who had anxiety and those who did not have anxiety.  Also, there were no significant 
differences observed in annual mean hospital days spent between individuals who had 
asthma and those who did not have asthma.  With every unit increase in Charlson 
comorbidity index score, there was an additional 0.26 mean annual days at the hospital 
(p<0.001).     
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Table 16. Association between Osteoarthritis and Annual Incremental utilization of 
Hospital days (n=26,992)  
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 0.06 0.06 0.287  
 Region 
Northeast Reference    
Midwest -0.03 0.04 0.456  
South 0.01 0.04 0.896  
 West 0.07 0.07 0.340  
 Age 0.001 0.001 0.336  
 Sex  
 Male Reference 
Female 0.04 0.05 0.447  
 Race 
White Reference 
Black 0.10 0.04 0.032  
Other 0.05 0.07 0.495  
Marital Status 
Married Reference 
Widowed 0.05 0.07 0.468  
Divorced -0.02 0.05 0.891  
Separated 0.04 0.09 0.646  
Never married -0.04 0.06 0.500  
Degree 
No degree Reference 
 GED -0.04 0.08 0.575  
High School Diploma 0.05 0.05 0.316  
Bachelor’s degree -0.04 0.06 0.490  
Masters or Doctorate 0.07 0.12 0.533  
Other degree -0.07 0.06 0.297  
Insurance coverage 
Private Reference 
Public 0.32 0.06 <0.001  
Uninsured -0.07 0.05 0.213  
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Table 16. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension  
No hypertension Reference 
Has hypertension 0.13 0.04 0.006  
Hyperlipidemia   
No hyperlipidemia Reference 
Has hyperlipidemia 0.01 0.04 0.844  
Anxiety    
No anxiety Reference 
Has anxiety 0.10 0.05 0.070 
Asthma   
No asthma Reference 
Has asthma 0.02 0.09 0.775  
Charlson Comorbidity Index 0.26 0.03 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
in the independent variable, given a specific starting value for the independent variable 
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Association between Osteoarthritis and Incremental Annual Outpatient visits  
Results of incremental utilization of outpatient days associated with osteoarthritis 
is reported in Table 17.   Mean annual outpatient visits were significantly higher for 
individuals with osteoarthritis as compared to individuals without osteoarthritis (3.63 
visits, p<0.001).  With every year increase in age, there was 0.08 increase in outpatient 
visits (p<0.001).  There were significantly greater mean annual outpatient visits by 
females as compared to males (1.73 visits, p<0.001).  Black individuals had fewer mean 
annual outpatient visits as compared to whites (1.53 visits, p<0.001).   Individuals who 
belonged to other races also had fewer mean annual outpatient visits as compared to 
whites (1.31 visits, p<0.001).  Individuals with high school degree had higher mean 
annual outpatient visits as compared to individuals without degree (0.62 visits, p=0.029).  
Individuals with bachelor’s degree had higher mean annual outpatient visits as compared 
to individuals without degree (2.31 visits, p<0.001).  Individuals with master’s degree or 
doctorate degree had higher mean outpatient visits as compared to individuals without 
degree (2.60 visits, p<0.001).  Individuals who were uninsured had fewer mean annual 
outpatient visits as compared to individuals with private insurance (3.08 visits, p<0.001). 
Among comorbid conditions, individuals with hypertension showed significant 
higher mean annual outpatient visits as compared to individuals without hypertension 
(1.21 visits, p<0.001).  Individuals with hyperlipidemia showed significant higher mean 
annual outpatient visits as compared to individuals without hyperlipidemia (1.10 visits, 
p<0.001).  Individuals with anxiety showed significant mean annual outpatient visits as 
compared to individuals without anxiety (4.10 visits, p<0.001).  .     
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Table 17.  Association between Osteoarthritis and Annual Incremental Outpatient visits 
(n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis   3.63 0.50 <0.001  
 Region 
Northeast Reference    
Midwest -0.38 0.41 0.361 
South -1.52 0.41 <0.001  
 West -0.06 0.40 0.884  
 Age 0.08 0.01 <0.001  
 Sex  
 Male Reference 
Female 1.73 0.22 <0.001  
 Race 
White Reference 
Black -1.53 0.27 <0.001  
Other -1.31 0.36 <0.001  
Marital Status 
Married Reference 
Widowed -0.96 0.35 0.007  
Divorced 0.32 0.33 0.325  
Separated 0.10 0.85 0.904  
Never married 0.78 0.38 0.039  
Degree 
No degree Reference 
 GED 0.80 0.66 0.225  
High School Diploma 0.62 0.28 0.029  
Bachelor’s degree 2.31 0.38 <0.001  
Masters or Doctorate 2.60 0.49 <0.001  
Other degree 1.04 0.43 0.016  
Insurance coverage 
Private Reference 
Public 0.55 0.30 0.068  
Uninsured   -3.08 0.30 <0.001  
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Table 17. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension  
No hypertension Reference  
Has hypertension 1.21 0.27 <0.001  
Hyperlipidemia  
No hyperlipidemia Reference  
Has hyperlipidemia 1.10 0.23 <0.001  
Anxiety  
No Anxiety Reference  
Has Anxiety 4.10 0.46 <0.001  
Asthma 
No Asthma Reference 
Has Asthma 1.15 0.45 0.011  
Charlson Comorbidity Index 1.86 0.13 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Emergency room utilization  
Results of incremental utilization of emergency rooms associated with 
osteoarthritis is reported in Table 18.  Mean annual emergency room visits were 
significantly higher for individuals with osteoarthritis as compared to individuals without 
osteoarthritis (0.009 visits, p<0.001).   With every year increase in age, there was 0.002 
decrease in mean annual emergency room visits (p<0.001).  There was no significant 
difference between males and females with respect to the utilization of emergency rooms 
(p=0.958).  Individuals who were widowed had higher mean annual utilization of 
emergency rooms as compared to individuals who were married (0.07 visits, p=0.001).  
Individuals who were divorced also had higher annual mean utilization of emergency 
rooms as compared to individuals who were married (0.07 visits, p=0.001).  Individuals 
with bachelor’s degree had significantly fewer mean annual emergency room visits as 
compared to individuals without degree (0.09 visits, p<0.001).  Individuals with master’s 
or doctorate degree had significantly fewer mean annual emergency room visits as 
compared to individuals without degree (0.07 visits, p=0.008).  Individuals who had 
public insurance had higher annual mean emergency room visits as compared to 
individuals with private insurance (0.13 visits, p<0.001). Among comorbid conditions, 
individuals with hypertension showed significant higher annual mean emergency room 
visits as compared to individuals without hypertension (0.07 visits, p<0.001).  Individuals 
with anxiety showed significant higher mean annual emergency room visits as compared 
to individuals without anxiety (0.12 visits, p<0.001).   
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Table 18. Association between Osteoarthritis and Annual Incremental Emergency room 
utilization (n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 0.09 0.02 <0.001  
 Region 
Northeast Reference    
Midwest 0.01 0.02 0.670 
South -0.03 0.02 0.121 
 West -0.05 0.02 0.003  
 Age -0.002 0.0004 <0.001  
 Sex  
 Male Reference 
Female 0.0006 0.01 0.958  
 Race 
 White Reference 
Black 0.05 0.01 <0.001  
Other -0.02 0.02 0.194  
Marital Status 
 Married Reference 
Widowed 0.07 0.02 0.001  
Divorced 0.07 0.02 0.001  
Separated 0.06 0.03 0.088  
Never married 0.03 0.02 0.081  
Degree 
 No degree Reference 
 GED 0.02 0.03 0.543  
High School Diploma -0.01 0.01 0.472  
Bachelor’s degree -0.09 0.02 <0.001  
Masters or Doctorate -0.07 0.03 0.008  
Other degree -0.06 0.01 0.001  
Insurance coverage 
Private Reference 
Public 0.13 0.02 <0.001  
Uninsured 0.01 0.01 0.545  
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Table 18. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension  
No hypertension Reference 
Has hypertension 0.07 0.12 <0.001  
Hyperlipidemia  
No hyperlipidemia Reference 
Has hyperlipidemia -0.04 0.02 0.034  
Anxiety  
No anxiety Reference 
Has anxiety 0.12 0.02 <0.001  
Asthma  
No Asthma Reference 
Has Asthma 0.03 0.02 0.230  
Charlson Comorbidity Index 0.05 0.01 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 





Association between Osteoarthritis and Incremental Annual Inpatient Expenditures  
Results of annual incremental inpatient expenditures associated with osteoarthritis 
is reported in Table 19.  Mean annual inpatient expenditures were significantly greater for 
individuals with osteoarthritis as compared to individuals without osteoarthritis ($826.38, 
p=0.021).   With every year increase in age, there was $12.61 increase in mean annual 
inpatient expenditures (p=0.031).  There were no significant differences in mean annual 
inpatient expenditures observed between males and females.  Black individuals had 
significantly higher mean annual inpatient expenditures as compared to whites ($387.50, 
p=0.050).   Individuals who were never married had significantly lower annual mean 
inpatient expenditures as compared to married individuals ($513.82, p=0.006).  
Individuals who were uninsured had lower annual mean inpatient expenditures as 
compared to individuals with private insurance ($819.42, p<0.001). 
Among comorbid conditions, individuals with hypertension showed no significant 
difference in inpatient expenditures as compared to individuals without hypertension 
(p=0.083).  Individuals with hyperlipidemia showed no significant difference in inpatient 
expenditures as compared to individuals without hyperlipidemia (p=0.702).  Individuals 
with anxiety showed no significant difference in inpatient expenditures as compared to 
individuals without anxiety (p=0.309).  Individuals with asthma showed no significant 
difference in inpatient expenditures as compared to individuals without asthma 
(p=0.333).  With every unit increase in Charlson comorbidity index score, there was an 
additional $772.95 spent in mean inpatient expenditures annually (p<0.001).    
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Table 19. Association between Osteoarthritis and Annual Incremental Inpatient 
Expenditures (n=26,992)  
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Osteoarthritis 826.38 357.33 0.021  
 Region 
Northeast Reference    
Midwest 72.25 187.92 0.701 
South 42.92 182.95 0.814  
 West 377.84 241.70 0.118  
 Age 12.61 5.83 0.031  
Sex  
 Male Reference 
Female 66.69 170.77 0.696  
Race 
White Reference 
Black 387.50 197.50 0.050  
Other -178.22 259.57 0.492  
Marital Status 
Married Reference 
Widowed -336.37 239.65 0.160  
Divorced -80.04 251.27 0.750  
Separated -300.71 315.80 0.341 
Never married -513.82 187.42 0.006  
Degree 
No degree Reference 
 GED 139.20 382.91 0.716  
High School Diploma 97.03 235.94 0.681  
Bachelor’s degree -119.22 274.12 0.664  
Masters or Doctorate 482.72 465.61 0.300  
Other degree -197.09 287.25 0.493  
Insurance coverage 
Private Reference 
Public 241.07 200.79 0.230  
Uninsured -819.42 173.43 <0.001  
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Table 19. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension  
No hypertension Reference 
Has hypertension 316.33 182.68 0.083 
Hyperlipidemia  
No hyperlipidemia Reference 
Has hyperlipidemia 77.55 202.84 0.702  
Anxiety  
No Anxiety Reference 
Has anxiety 243.44 251.45 0.333  
Asthma  
No asthma Reference 
Has asthma -107.35 246.20 0.663  
Charlson Comorbidity Index 772.95 104.73 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 





Association between Osteoarthritis and Incremental Annual Outpatient expenditures  
Results of annual incremental outpatient expenditures associated with 
osteoarthritis is reported in Table 20.   Mean annual outpatient expenditures were 
significantly higher for individuals with osteoarthritis as compared to individuals without 
osteoarthritis ($658.94, p<0.001).  With every year increase in age, there was $20.67 
increase in mean annual outpatient expenditures (p<0.001).  There were significantly 
higher mean annual outpatient expenditures for females as compared to males ($223.43, 
p=0.012).   Black individuals had significantly lower mean annual outpatient 
expenditures as compared to whites ($276.32, p=0.015).  Individuals who were widowed 
had significantly lower annual mean outpatient expenditures as compared to individuals 
who were married ($388.92, p=0.015).   Individuals who had public insurance had lower 
annual mean outpatient expenditures as compared to individuals with private insurance 
($405.77, p<0.001).  Individuals who were uninsured had lower outpatient expenditures 
as compared to individuals with private insurance ($1,205.95, p<0.001).  Individuals with 
bachelor’s degree had significantly higher outpatient expenditures as compared to 
individuals without degree ($830.02, p<0.001).    
Among comorbid conditions, individuals with hypertension had significantly 
higher outpatient expenditures as compared to individuals without hypertension ($298.83, 
p=0.005).  Individuals with hyperlipidemia showed higher significant mean annual 
outpatient expenditures as compared to individuals without hyperlipidemia ($319.05, 
p=0.001).  Individuals with anxiety had significantly higher mean annual outpatient 
expenditures as compared to individuals without anxiety ($778.26, p<0.001).  
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Table 20.  Association between Osteoarthritis and Annual Incremental Outpatient 
Expenditures (n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 658.94 154.29 <0.001  
 Region 
Northeast Reference    
Midwest -263.93 129.21 0.041 
South -413.90 132.14 0.002  
 West -134.07 150.98 0.375  
Age 20.67 3.64 <0.001  
 Sex  
 Male Reference 
Female 223.43 88.79 0.012  
 Race 
White Reference 
Black -276.32 113.52 0.015  
Other -440.13 115.33 <0.001  
Marital Status 
 Married Reference 
Widowed -388.92 159.14 0.015  
Divorced 86.68 137.24 0.528  
Separated -125.36 267.94 0.640 
Never married -100.65 111.73 0.368  
Degree 
 No degree Reference 
 GED 275.44 174.73 0.115  
High School Diploma 421.05 110.64 <0.001  
Bachelor’s degree 830.02 135.64 <0.001  
Masters or Doctorate 802.04 185.03 <0.001  
Other degree 415.57 146.99 0.005  
Insurance coverage 
Any private insurance Reference 
Public -405.77 98.04 <0.001    
Uninsured -1205.95 104.39 <0.001  
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Table 20. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension  
 No hypertension Reference 
Has hypertension 298.83 105.34 0.005 
Hyperlipidemia 
 No hyperlipidemia Reference 
Has hyperlipidemia 319.05 100.41 0.001  
Anxiety  
 No anxiety Reference 
Has anxiety   778.26 173.65 <0.001  
Asthma  
 No asthma Reference 
Has asthma 33.31 163.08 0.838  
Charlson Comorbidity Index 743.95 57.59 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Emergency Expenditures  
Results of annual incremental emergency room expenditures associated with 
osteoarthritis is reported in Table 21.  Emergency room expenditures were not 
significantly different for individuals with osteoarthritis as compared to individuals 
without osteoarthritis (p=0.663).  With every unit increase in age, there was $1.72 
decrease in emergency room expenditures (p=0.010).  There were no significant 
differences in emergency room expenditures between males and females (p=0.368).   
Individuals who were uninsured had lower emergency room expenditures as compared to 
individuals with private insurance ($62.88, p=0.001).  Individuals with bachelor’s degree 
had significantly lower emergency room expenditures as compared to individuals without 
degree ($90.22, p=0.035).  Individuals with master’s degree or doctorate degree had 
significantly lower emergency room expenditures as compared to individuals without 
degree ($100.86, p=0.014).   
Among comorbid conditions, individuals with hypertension had significantly 
higher emergency room expenditures as compared to individuals without hypertension 
($81.85, p=0.004).  Individuals with anxiety showed significant emergency room 
expenditures as compared to individuals without anxiety ($137.96, p<0.001).  With every 
unit increase in Charlson comorbidity index score, there was an additional $50.17 spent 
in mean emergency expenditures annually (p<0.001).   
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Table 21. Association between Osteoarthritis and Annual Incremental Emergency room 
Expenditures (n=26,992)  
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 11.92 29.61 0.687  
 Region 
Northeast Reference    
Midwest 32.17 27.30 0.239 
South 11.38 23.86 0.633  
 West -15.55 28.06 0.579  
 Age -1.90 0.73 0.009  
 Sex  
 Male Reference 
Female 14.44 16.37 0.378  
 Race 
White Reference 
Black 28.21 21.76 0.195  
Other -34.24 33.55 0.308  
Marital Status 
Married Reference 
Widowed -14.00 37.52 0.709  
Divorced 74.79 37.25 0.045  
Separated 39.21 44.59 0.379 
Never married -20.33 21.64 0.347  
Degree 
 No degree Reference 
 GED -82.52 47.44 0.082  
High School Diploma -32.05 40.54 0.429  
Bachelor’s degree -93.18 44.40 0.036  
Masters or Doctorate -103.79 42.60 0.015  
Other degree -87.18 49.31 0.077  
Insurance coverage 
 Private Reference 
Public -21.57 20.72 0.298 
Uninsured -68.23 20.58 0.001  
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Table 21. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension  
No hypertension Reference 
Has hypertension 84.05 29.30 0.004  
Hyperlipidemia   
No hyperlipidemia Reference 
Has hyperlipidemia -18.92 29.65 0.523  
 Anxiety  
No anxiety Reference  
Has anxiety 141.42 36.81 0.000  
 Asthma  
No asthma Reference 
Has asthma 4.17 27.39 0.879  
Charlson Comorbidity Index 51.80 9.75 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
in the independent variable, given a specific starting value for the independent variable. 
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Association between Osteoarthritis and Incremental Annual Miscellaneous Expenditures  
Results of annual incremental other miscellaneous medical expenditures including 
medical equipment, supplies, glasses and other medical items associated with 
osteoarthritis is reported in Table 22.  Annual mean miscellaneous expenditures were not 
significantly different for individuals with osteoarthritis as compared to individuals 
without osteoarthritis (p=0.117).  With every year increase in age, there was $2.23 
increase in mean annual miscellaneous expenditures (p<0.001).  There was no significant 
difference in mean annual miscellaneous expenditures between males and females 
(p=0.106).   Black individuals had significantly lower mean annual miscellaneous 
expenditures as compared to whites ($22.71, p=0.005).  Individuals who had public 
insurance had lower annual mean miscellaneous expenditures as compared to individuals 
with private insurance ($26.28, p=0.015).  Individuals with bachelor’s degree had 
significantly higher annual mean miscellaneous expenditures as compared to individuals 
without degree ($53.08, p<0.001).  Individuals with master’s degree or doctorate degree 
had significantly higher annual mean miscellaneous expenditures as compared to 
individuals without degree ($61.92, p=0.003).   
Among comorbid conditions, individuals with hypertension had no significant 
difference in annual mean miscellaneous expenditures as compared to individuals without 
hypertension (p=0.526).    With every unit increase in Charlson comorbidity index score, 
there was an additional $22.50 spent in mean miscellaneous expenditures annually 
(p<0.001).   
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Table 22.  Association between Osteoarthritis Annual Incremental Miscellaneous 
expenditures (n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 27.96 17.85 0.117  
 Region 
Northeast Reference    
Midwest 9.35 12.88 0.468 
South -4.99 11.01 0.651  
 West 18.01 12.68 0.156  
 Age 2.23 0.39 <0.001  
 Sex  
 Male Reference 
Female 12.73 7.88 0.106  
 Race 
White Reference 
Black -22.71 8.15 0.005  
Other 15.60 18.23 0.392  
Marital Status 
Married Reference 
Widowed 1.41 15.60 0.928  
Divorced 15.47 14.14 0.274  
Separated -32.74 24.19 0.176 
Never married 23.27 15.63 0.137  
Degree 
No degree Reference 
GED -2.18 16.88 0.897  
High School Diploma 17.37 8.63 0.044  
Bachelor’s degree   53.08 13.12 <0.001  
Masters or Doctorate 61.92 21.09 0.003  
Other degree 13.13 15.12 0.385  
Insurance coverage 
Private Reference 
Public -26.28 10.84 0.015  
Uninsured -75.15 7.06 <0.001  
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Table 22. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension 
No hypertension Reference 
Has hypertension 7.12 11.24 0.526  
Hyperlipidemia  
No hyperlipidemia 
Has hyperlipidemia 14.84 11.88 0.211  
 Anxiety 
No anxiety 
Has anxiety 29.76 21.75   0.171  
 Asthma 
No asthma 
Has asthma 3.09 18.72 0.869  
Charlson Comorbidity Index 22.50 4.39 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Medication Expenditures  
Results of annual incremental medication expenditures associated with 
osteoarthritis is reported in Table 23.  Annual mean medication expenditures were 
significantly higher for individuals with osteoarthritis as compared to individuals without 
osteoarthritis ($325.03, p=0.013).  With every year increase in age, there was $17.75 
increase in mean annual medication expenditures (p<0.001).  There was no significant 
difference in medication expenditures between males and females (p=0.41).   Black 
individuals had significantly lower annual mean medication expenditures as compared to 
whites ($361.94, p<0.001).  Individuals who had public insurance had higher medication 
expenditures as compared to individuals with private insurance ($567.61, p<0.001).  
Individuals with bachelor’s degree had significantly higher medication expenditures as 
compared to individuals without degree ($417.41, p=0.011).  Individuals with master’s 
degree or doctorate degree had significantly higher medication expenditures as compared 
to individuals without degree ($516.66, p=0.024).   
Among comorbid conditions, individuals with hypertension had higher mean 
annual medication expenditures as compared to individuals without hypertension 
($422.22, p<0.001).  Individuals with hyperlipidemia had higher annual mean medication 
expenditures as compared to individuals without hyperlipidemia ($802.67, p<0.001).  
Individuals with anxiety had higher annual mean medication expenditures as compared to 
individuals without anxiety ($1,028.34, p<0.001).  Individuals with asthma had higher 
annual mean medication expenditures as compared to individuals without asthma 
($1,096.23, p<0.001).  
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Table 23. Association between Osteoarthritis and Annual Incremental Medication 
Expenditures (n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 325.03 130.27 0.013  
 Region 
Northeast Reference    
Midwest -265.18 176.97 0.134 
South -200.56 155.90 0.198  
 West -250.49 170.01 0.141  
 Age 17.75 4.03 <0.001  
 Sex  
 Male Reference 
Female -71.91 98.08 0.463  
 Race 
White Reference 
Black -361.94 97.32 <0.001 
Other -3.48 254.34 0.989  
Marital Status 
Married Reference 
Widowed -142.40 132.14 0.281  
Divorced -46.58 121.37 0.701  
Separated -132.27 185.74 0.476 
Never married 46.83 135.40 0.729  
Degree 
No degree Reference 
GED 1738.76 1180.24 0.141    
High School Diploma 185.01 119.10 0.120  
Bachelor’s degree 417.41 165.01 0.011  
Masters or Doctorate 516.66 229.52 0.024  
Other degree 38.52 155.07 0.804  
Insurance coverage 
Private Reference 
Public 567.61 146.62 <0.001  
Uninsured -715.10 103.85 <0.001  
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Table 23. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension 
No hypertension Reference 
Has hypertension 422.22 89.94 <0.001  
Hyperlipidemia  
No hyperlipidemia Reference  
Has hyperlipidemia 802.67 93.73 <0.001  
 Anxiety 
No anxiety Reference 
Has anxiety 1028.34 134.05 <0.001  
 Asthma  
No asthma Reference 
Has asthma 1096.23 316.16 <0.001  
Charlson Comorbidity Index 731.59 67.15 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
in the independent variable, given a specific starting value for the independent variable 
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Association between Osteoarthritis and Incremental Annual Total Expenditures  
Results of annual incremental total expenditures associated with osteoarthritis is 
reported in Table 24.  Mean annual total expenditures were significantly higher for 
individuals with osteoarthritis as compared to individuals without osteoarthritis 
($2,045.75, p=0.001).  With every year increase in age, there was $52.14 increase in 
annual mean total expenditures (p<0.001).  There was no significant difference in mean 
annual total expenditures between males and females (p=0.053).   Individuals who had no 
insurance had lower annual mean total expenditures as compared to individuals with 
private insurance ($2,779.96, p<0.001).  Individuals with master’s degree or doctorate 
degree had significantly higher total expenditures as compared to individuals without 
degree ($1,470.84, p=0.014).   
Among comorbid conditions, individuals with hypertension had higher mean 
annual total expenditures as compared to individuals without hypertension ($973.03, 
p=0.001).   Individuals with hyperlipidemia had higher mean annual total expenditures as 
compared to individuals without hyperlipidemia ($1,238.88, p=<0.001).  Individuals with 
anxiety had significant higher annual mean total expenditures as compared to individuals 
without anxiety ($2082.09, p<0.001).  With every unit increase in Charlson comorbidity 




Table 24.  Association between Osteoarthritis and Annual Incremental Total 
Expenditures (n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 2045.75 603.94 0.001 
 Region 
Northeast Reference    
Midwest -444.38 318.52 0.163 
South -535.93 331.77 0.106  
 West 135.04 392.16 0.731  
 Age    52.14 8.87 <0.001  
 Sex  
 Male Reference 
Female 477.48 246.67 0.053  
 Race 
White Reference 
Black -486.33 261.11 0.063  
Other -156.25 677.23 0.818  
Marital Status 
Married Reference 
Widowed -819.21 404.33 0.043  
Divorced 302.09 414.58 0.466  
Separated -46.44 778.33 0.952 
Never married -599.24 273.30 0.028  
Degree 
No degree Reference 
 GED 2762.10 1893.92 0.145  
High School Diploma 689.18 407.53 0.091  
Bachelor’s degree 819.10 473.56 0.084  
Masters or Doctorate 1470.84 596.92 0.014  
Other degree 258.22 480.86 0.591  
Insurance coverage 
Private Reference 
Public 618.82 340.10 0.069  
Uninsured -2779.76 263.00 <0.001  
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  Table 24. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Hypertension 
No hypertension Reference 
Has hypertension 973.03 293.22 0.001 
Hyperlipidemia  
No hyperlipidemia Reference 
Has hyperlipidemia 1238.88 331.02 <0.001  
Anxiety  
No anxiety Reference 
Has anxiety 2082.09 347.44 <0.001  
Asthma  
No asthma Reference 
Has asthma 1066.63 678.76 0.116  
Charlson Comorbidity Index 2404.08 160.13 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Absenteeism  
Results of annual absenteeism associated with osteoarthritis is reported in Table 
25.  Annual absenteeism was significantly higher for individuals with osteoarthritis as 
compared to individuals without osteoarthritis (2.21 days, p=0.042).  With every unit 
increase in age, there was 0.03 increase in absenteeism (p=0.030).  Females had 
significant higher absenteeism than males (1.96 days, p<0.001).   Individuals who had 
public insurance had higher absenteeism as compared to individuals with private 
insurance (2.52 days, p=0.007).  Individuals with bachelor’s degree had significantly 
lower absenteeism as compared to individuals without degree (3.16 days, p=0.005).  
Individuals with master’s degree or doctorate degree had significantly lower absenteeism 
as compared to individuals without degree (4.22 days, p<0.001).   
Among comorbid conditions, individuals with hypertension had higher significant 
absenteeism as compared to individuals without hypertension (1.58 days, p=0.011).   
There were no significant differences in annual absenteeism between individuals with 
hyperlipidemia and individuals without hyperlipidemia. There were also no significant 
differences observed between individuals with anxiety and individuals without anxiety 
for annual absenteeism.  Individuals with asthma did not show any significant difference 
in annual absenteeism as compared to individuals without asthma.  Individuals with 
higher Charlson Comorbidity Index scores had higher absenteeism as compared to 
individuals with lower Charlson Comorbidity index scores (1.48 days, p<0.001) 
.  
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Table 25.  Association between Osteoarthritis and Annual Incremental Annual 
Absenteeism (n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
 Osteoarthritis 2.21 1.09 0.042 
 Region 
Northeast Reference    
Midwest -0.74 0.53 0.169 
South -0.54 0.56 0.310  
 West -1.08 0.53 0.045  
Age 0.03 0.01 0.030  
 Sex  
 Male Reference 
Female 1.96 0.39 <0.001  
 Race 
White Reference 
Black 0.39 0.46 0.401  
Other 0.49 0.69 0.487  
Marital Status 
Married Reference 
Widowed -0.91 1.50 0.546  
Divorced -0.08 0.51 0.873  
Separated/never married -0.33 0.44 0.454  
Degree 
No degree Reference 
 GED -0.07 2.11 0.973  
High School Diploma -2.11 1.09 0.053  
Bachelor’s degree -3.16 1.12 0.005  
Masters or Doctorate   -4.22 1.15 <0.001  
Other degree   -2.66 1.15 0.021  
Insurance coverage 
Private Reference 
Public 2.52 0.93 0.007  
Uninsured -0.51 0.46 0.274  
Hypertension  
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Table 25. cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
No hypertension Reference  
Has hypertension 1.58 0.62 0.011 
Hyperlipidemia  
No hyperlipidemia Reference 
Has hyperlipidemia -0.13 0.58 0.817  
Anxiety  
No anxiety Reference 
Has anxiety 1.34 0.70 0.056  
Asthma  
No asthma Reference 
Has asthma -0.12 0.65 0.845    
Charlson Comorbidity Index 1.48 0.21 <0.001 
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Absenteeism Expenditures  
Results of annual absenteeism costs associated with osteoarthritis is reported in 
Table 26.  Annual absenteeism costs was significantly higher for individuals with 
osteoarthritis as compared to individuals without osteoarthritis ($715.74, p=0.05).  With 
every unit increase in age, there was 8.91 increase in absenteeism costs (p=0.002).  
Females had significantly higher absenteeism costs than males ($206.85, p=0.001).   
Individuals who had no insurance had lower absenteeism costs as compared to 
individuals with private insurance ($321.73, p<0.001).  Individuals with bachelor’s 
degree had significantly higher absenteeism costs as compared to individuals without 
degree ($269.14, p=0.015).  Individuals with master’s degree or doctorate degree had 
significantly higher absenteeism costs as compared to individuals without degree 
($255.36, p=0.048).   
Among comorbid conditions, individuals with hypertension had higher significant 
absenteeism costs as compared to individuals without hypertension ($234.90, p=0.016).    
There were no significant differences in annual absenteeism costs between individuals 
with hyperlipidemia and individuals without hyperlipidemia. There were also no 
significant differences observed between individuals with anxiety and individuals without 
anxiety for annual absenteeism costs.  Individuals with asthma did not show any 
significant difference in annual absenteeism costs as compared to individuals without 
asthma.  Individuals with higher Charlson Comorbidity Index scores had higher 
absenteeism costs as compared to individuals with lower Charlson Comorbidity index 
scores ($212.28, p<0.001).  
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Table 26.  Association between Osteoarthritis and Annual Incremental Absenteeism 
Expenditures (n=26,992) 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
Osteoarthritis   715.74 370.63 0.050 
 Region 
 Northeast Reference    
Midwest -195.97 81.90 0.017 
South -127.40 91.67 0.165  
 West -210.38 82.13 0.010  
Age  8.91 2.88 0.002  
 Sex  
 Male Reference 
Female 206.85 59.93 0.001  
 Race 
White Reference 
Black 51.45 77.96 0.509  
Other 31.89 87.12 0.714  
Marital Status 
Married Reference 
Widowed -315.62 185.29 0.089  
Divorced 7.40 96.59 0.939  
Separated/never married -216.98 66.36 0.001  
Degree 
No degree Reference 
 GED 58.06 118.60 0.624  
High School Diploma 152.84 93.23 0.101  
Bachelor’s degree   269.14 110.24 0.015  
Masters or Doctorate 255.36 129.07 0.048  
Other degree   236.08 110.07 0.032  
Insurance coverage 
Private Reference 
Public -161.95 93.45 0.083  
Uninsured -321.73 62.82 <0.001  
Hypertension  
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Table 26. Cont’d 
________________________________________________________________________ 
  Marginal effect Standard error Prob.  
________________________________________________________________________ 
No hypertension Reference 
Has hypertension 234.90 97.18 0.016  
Hyperlipidemia  
No hyperlipidemia Reference 
Has hyperlipidemia   -112.44 73.91 0.128  
Anxiety  
No anxiety Reference 
Has anxiety 141.66 107.16 0.186  
Asthma  
No asthma Reference 
Has asthma -32.71 115.01 0.776  
Charlson Comorbidity Index 212.28 45.58 <0.001  
________________________________________________________________________ 
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete 
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to  osteoarthritis and females to males 
 Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change 
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SUMMARY AND CONCLUSIONS 
Background 
Osteoarthritis is the most common form of arthritis where there is progressive 
degeneration of cartilage in the joint (Felson and Nevitt 2004).   Symptoms of 
osteoarthritis include pain, swelling or stiffness, or a combination (Altman, Alarcon et al. 
1990).  Joints commonly affected by osteoarthritis include knee, hip, hand, spine and foot 
(Newman et al. 2003).   In the United States, it was estimated that twenty-seven million 
adults or 12.1 percent of the adult population suffered from osteoarthritis in 2005 
(Lawrence, Felson et al. 2008).  Risk of osteoarthritis increases with age (Felson, 
Naimark et al. 1987; Kallman, Wigley et al. 1990; Losina, Weinstein et al. 2013).  
Incidence of osteoarthritis is significantly greater in women than men (Oliveria, Felson et 
al. 1995; Srikanth, Fryer et al. 2005).  Occupations that include bending and lifting have 
been associated with greater risk of osteoarthritis (Felson, Hannan et al. 1991; Coggon, 
Kellingray et al. 1998).  Strenuous physical activity (Buckwalter and Lane 1997; Kujala, 
Kettunen et al. 1995)  and genetic factors (Spector and MacGregor 2004) are some other 
risk factors identified with osteoarthritis.   
There is wide variation in the estimates of direct health care utilization and costs 
among studies examining incremental costs due to osteoarthritis. This study provides a 
current description of the utilization and expenditures of health care resources associated 
with osteoarthritis.  Estimates of incremental utilization and incremental costs of direct 
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healthcare associated with osteoarthritis as well as incremental absenteeism and 
incremental absenteeism costs associated with osteoarthritis were developed. 
Objectives 
 The goal of this study was to assess burden associated with osteoarthritis.  The 
specific objectives of the study were to:  
1. determine incremental annual direct health care resource utilization associated 
with osteoarthritis by categories including  hospitalizations, hospital days, 
emergency room encounters, and outpatient visits 
2. determine incremental annual direct health care expenditures associated with 
osteoarthritis by categories including total expenditures, inpatient hospital 
expenditures, emergency room expenditures, outpatient expenditures, medication 
expenditures and miscellaneous expenditures  
3. determine incremental annual number of days absent from work associated with 
osteoarthritis and 
4. determine incremental annual absenteeism costs associated with osteoarthritis  
Hypotheses 
The study hypotheses were: 
1. presence of osteoarthritis will increase annual direct utilization of  health care 
resources, including increase in  hospitalizations, hospital days, emergency room 
encounters, and outpatient room visits 
2. presence of osteoarthritis will increase annual direct health care expenditures, 
including increase in total expenditures, inpatient hospital expenditures, 
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emergency room expenditures, outpatient expenditures, medication expenditures 
and  miscellaneous expenditures  
3. presence of osteoarthritis will increase annual absenteeism from workplace and  
4. presence of osteoarthritis will increase annual absenteeism costs from workplace 
Methods 
An observational database analysis was conducted using data from the Medical 
Expenditure Panel Survey (MEPS).   Individuals eighteen years old or older with 
osteoarthritis were compared to individuals without osteoarthritis.  A one-year study 
interval was used for analyses.  The study was approved by the Institutional Review 
Board of Purdue University. 
Sample 
 Individuals eighteen years or older and employed in 2011 were included in the 
study. ICD-9-CM codes were used to identify employees with osteoarthritis: 715 for 
osteoarthritis and other allied disorders.  Individuals diagnosed with osteoarthritis were 
compared to individuals without any diagnosis of osteoarthritis.  Individuals missing any 
information on number of days missed at work in 2011 were excluded.  Individuals who 
had missing information for their wages in MEPS were excluded.   
Study Variables 
Study variables included a predictor variable of osteoarthritis that was coded as 
‘1’ for presence of the disease and ‘0’ for absence of the disease.   Covariates in the 
model included age, coded as a continuous variable, gender, coded as a binary variable 
with ‘0’ for males and ‘1’ for females.  Race was coded as a categorical variable 
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including “1” for White, “2” for Black,“3” for others.  Region was coded as a categorical 
variable including “1” for Northeast, “2” for Midwest, “3” for South, and “4” for West.   
Marital status categories included “1” for married, “2” for widowed, “3” for separated, 
“4” for divorced and “5” for never married.  Highest degree obtained by an individual 
was coded as “1” for no degree, “2” for general education degree (GED), “3” for high 
school diploma, “4” for bachelor’s degree, “5” for master’s degree or doctorate degree 
and “6” for other degree.   Health insurance status was coded as a categorical variable 
with three categories, “1” as private insurance, and “2” as public insurance and “3” for no 
insurance.  Comorbid disease conditions including hypertension, hyperlipidemia, anxiety 
and asthma were also included.  Each comorbid disease was coded as ‘1’ for presence of 
the disease and ‘0’ for absence of the disease. 
Annual wages were divided by number of working days in 2011 to obtain daily 
wages.  Daily wage was coded as a continuous variable.  Daily wage was multiplied with 
annual days missed at the workplace to obtain annual absenteeism costs.   
Hospitalizations were determined by identifying and counting the number of 
unique confinements per patient.  Number of hospital days spent by each patient were 
identified by subtracting the patient’s admit date and discharge date at the hospital for 
each visit.  One visit at an outpatient facility defined as a summation of all visits to that 
facility per day.  Similarly, for an emergency room visit if a patient visited an emergency 
room once on a particular day, the resultant visit count for emergency room was one. 
Total annual emergency room expenditures and total annual outpatient 
expenditures per patient were calculated by adding facility-specific expenditures for the 
patient in the specified one-year period.  Total annual prescription expenditures per 
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patient, were calculated by adding standard prices for all medication claims during the 
specified one year period.  Total miscellaneous expenditures per patient were calculated 
by adding costs that did not belong in any other resource category during the specified 
one year period. 
  Statistical Analyses 
Data were analyzed using SAS for Unix Version 9.2 and STATA for Unix version 
12.   Frequency distributions were developed to describe the sample and Chi-square tests 
were used to assess statistical differences between persons with osteoarthritis and those 
without osteoarthritis on demographic variables and clinical variables.  Unadjusted means 
and 95 percent confidence intervals for annual hospitalizations, annual hospital stays, 
annual outpatient visits and annual emergency room visits were computed and Wilcoxon 
Mann Whitney tests were used to detect differences between the osteoarthritis and 
comparator group.  Similarly, unadjusted means and 95 percent confidence intervals were 
developed for annual inpatient expenditures, annual outpatient expenditures, annual 
emergency room expenditures, annual medication expenditures, annual miscellaneous 
expenditures and annual total expenditures. Wilcoxon Mann Whitney tests were used to 
detect differences between the osteoarthritis and comparator group.  Unadjusted means 
and 95 percent confidence intervals were calculated for annual absenteeism and annual 
absenteeism costs.  Wilcoxon Mann Whitney tests were used to detect differences 
between the osteoarthritis and comparator group.  
Individual zero inflated negative binomial regression models were developed to 
estimate independent association between osteoarthritis and hospitalizations, hospital 
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days, outpatient visits and emergency room visits.  A binary predictor variable for 
osteoarthritis was included in each model and covariates in each model included age, 
gender, race, region, marital status, insurance, education, presence of comorbid diseases 
including hypertension, hyperlipidemia, anxiety and asthma and Charlson Comorbidity 
Index scores.  Similar regression models for health care expenditures were developed, 
with the predictor variable and covariates described above, with individual models for 
total expenditures, hospital expenditures, outpatient expenditures, emergency room 
expenditures, medication expenditures and total expenditures.   Zero-inflated negative 
binomial models were also developed for assessing association of osteoarthritis with 
annual absenteeism and association of osteoarthritis with annual absenteeism costs.  
Predictor variable and covariates as described above were included in the models.  
 Results and Discussion 
Demographic characteristics of sample 
The total number of individuals who participated in MEPS Household Component 
of the Medical Expenditure Panel Survey in 2011 were 35,313.  After excluding 
individuals who were younger than eighteen years of age and unemployed, 26,992 
individuals remained.  Out of 26,992 individuals, 1,354 individuals had a diagnosis of 
osteoarthritis, representing 15,363,338 persons with osteoarthritis nationally.    
Incremental Annual Resource Utilization associated with Osteoarthritis 
Annual mean incremental hospitalizations associated with osteoarthritis in the 
current study were 0.07 hospitalizations (p<0.001).   Mean annual hospital days were not 
incrementally greater for individuals with osteoarthritis (0.06 days, p=0.287).  Mean 
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annual outpatient visits were significantly higher for individuals with osteoarthritis as 
compared to individuals without osteoarthritis (3.63 visits, p<0.001).  Mean annual 
emergency room visits were significantly higher for individuals with osteoarthritis as 
compared to individuals without osteoarthritis (0.009 visits, p<0.001). 
Findings from this study are consistent with findings from prior studies that 
reported higher utilizations for individuals with osteoarthritis as compared to individuals 
without osteoarthritis.   Le et al. and Berger et al., in different studies, compared 
individuals with osteoarthritis with individuals without osteoarthritis using Marketscan 
databases and calculated incremental healthcare utilization associated with osteoarthritis 
(Le, Montejano et al. 2012; Berger, Hartrick et al. 2011).  Mean annual incremental 
outpatient visits in this current study was 3.63 visits which was similar to the mean 
annual incremental outpatient visits reported by Le et al. at 3.1 visits and Berger et al. at 
3.9 visits.  However, when compared to findings by Le et al.  (Le, Monjetano et al. 2012), 
and findings by Berger et al. (Berger, Hartrick et al. 2011), incremental mean annual 
hospitalization was lower in the current study at 0.07 annual mean visits, as compared to 
the estimate provided by Le et al. and Berger et al. at 0.3 visits.   Mean incremental 
annual hospital days in the current study was 0.06 days as compared to 1.3 days as 
reported by Berger and colleagues.   
Berger et al. and Le et al. used samples similar to this current study by examining 
individuals eighteen years or older and employed.  A possible reason for variation in 
utilization estimates across studies may include differences in the process of data 
collection.  Berger et al. and Le et al. estimated utilizations from MarketScan® database 
which contains information from enrollment files and medical and outpatient pharmacy 
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claims from a variety of private insurers that provide health care coverage to their 
employees (Berger, Hartrick et al. 2011; Le, Montejano et al. 2012).  However, the 
current study employed MEPS database where the medical conditions and health care 
utilization reported by the individual in the survey were recorded by the interviewer as 
verbatim text, which was then coded by professional coders to fully-specified 2011 ICD-
9-CM codes.  Researchers have reported that the ability of survey respondents to report 
medical conditions that can be coded accurately should not be assumed to be precise in 
MEPS (Cox and Iachan, 1987; Johnson and Sanchez, 1993).  A study conducted by 
Zuvekas and Olin, compared participants in MEPS from 2001 to 2003 with Medicare 
coverage and matched them to their Medicare enrollment and claims data using Medicare 
health insurance claim numbers (HICNs) or social security numbers (SSNs).  The authors 
reported that individuals in the MEPS underreported utilization of health care services 
including underreporting of emergency room visits and physician office visits by 19 
percent (Zuvekas and Olin. 2009).   Lower utilization estimates in this current study can 
be attributed to the underreporting in the MEPS survey by individuals. 
Incremental Annual Expenditures associated with Osteoarthritis 
In the current study, mean annual incremental total expenditures associated with 
osteoarthritis were $2,045.75 (p=0.001).  Mean incremental inpatient expenditures were 
the largest component of direct health expenditures at $826.83 (p=0.021).  Mean 
incremental outpatient expenditures were significantly associated with osteoarthritis at 
$658.94 (p<0.05).  Mean annual incremental medications expenditures associated with 
osteoarthritis were $325.03 (p=0.013).  Mean annual incremental emergency 
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expenditures was not significantly associated at $11.93 (p<0.687).  Similarly, mean 
annual incremental miscellaneous expenditures associated with osteoarthritis were $27.96 
(p=0.117).    
In previous studies, incremental expenditures associated with osteoarthritis were 
reported with higher estimates.  Le and colleagues evaluated 258,237 individuals with 
osteoarthritis and matched them to the same number of individuals without osteoarthritis, 
using Marketscan® databases. They estimated mean total costs associated with 
osteoarthritis at $10,941 (Le, Montejano et al. 2012).  Similarly, Berger and colleagues 
using Marketscan® databases for 2007, estimated mean total costs associated with 
osteoarthritis at $8,060 (Berger, Hartrick et al. 2011).  The authors reported that presence 
of comorbidities including diabetes, hypertension, and cardiovascular disease which were 
not adjusted in the analyses could have resulted in high expenditure estimates (Berger, 
Hartrick et al. 2011; Le, Montejano et al. 2012). 
By using survey weights for MEPS, national estimates for this population of 
employed, individuals eighteen years or older were obtained for the current study.  A 
sample of 26,992 individuals in this study represents a population of 204,328,545 
nationally.   Total direct expenditures for this population was estimated at $41.7 billion 
with annual inpatient expenditures as major contributor at $16.8 billion dollars, followed 
by outpatient expenditures at $13.4 billion dollars, annual medication expenditures at 
$6.6 billion dollars, annual miscellaneous expenditures at 0.57 billion and annual 
emergency room expenditures at $0.24 billion.  
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Incremental Annual Absenteeism associated with Osteoarthritis 
Mean incremental absenteeism associated with osteoarthritis in the current study 
was estimated at 2.2 days annually.  Findings from previous studies in estimating annual 
incremental absenteeism were similar.   Berger et al. estimated annual incremental 
absenteeism costs between individuals with osteoarthritis and individuals without 
osteoarthritis using MarketScan® databases in 2007.  Annual incremental absenteeism 
related to sickness was estimated at 1.8 days (Berger, Hartrick et al. 2011).   Kotlarz and 
colleagues evaluated pooled data from 1996 to 2005 from MEPS and estimated 
incremental mean annual absenteeism of 1.8 days for women and 1.65 days for men due 
to osteoarthritis (Kotlarz, Gunnarsson et al. 2010).  Kotlarz et al. did not provide an 
annual average absenteeism estimate for an individual, irrespective of the gender.  
Incremental Annual Absenteeism Expenditures associated with Osteoarthritis 
Current study estimated mean annual incremental absenteeism costs at $715.74. 
Absenteeism costs were estimated by employing annual wages reported by individuals in 
MEPS in 2011.  However, 50 percent of the sample reported zero wages, despite being 
employed.  By removing the individuals who reported zero wages, the mean incremental 
absenteeism costs increased slightly by $784.37.  After removing individuals who 
reported zero wages, the number of individuals who remained in the sample were 10,320. 
After applying survey weights, 10,320 individuals were equivalent to a population of 
112,603,572 to obtain a population of employed, eighteen years or older individuals with 
wages greater than zero.  The mean absenteeism costs for this population was $8.8 billion 
dollars.  Kotlarz and colleagues using MEPS data estimated an aggregate annual 
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absenteeism costs of $4.8 billion for women and $5.5 billion for men.  Kotlarz and 
colleagues obtained the above costs by utilizing information from Morbidity and 
Mortality Weekly Report from Centers of Disease Control and Prevention, instead of 
completely relying on MEPS (Kotlarz, Gunnarsson et al. 2010).  This could explain the 
discrepancy in the absenteeism costs reported between the current study and by Kotlarz et 
al.  
Study Limitations 
A limitation of this study was that ICD-9-CM codes were used to identify 
individuals with osteoarthritis.  Also, the comorbidities used for the Charlson 
Comorbidity Index were identified using ICD-9-CM codes.  Use of diagnostic codes in 
claims to identify diagnosis is known to be imperfect due to variations in coding 
(Romano and Mark 1994).  However, the set of codes used in this study to identify 
osteoarthritis have been utilized in prior studies (Berger, Hartrick et al 2011; Le et al. 
2012).  Another limitation of this study was that MEPS does not specify the site of 
osteoarthritis (knee or hip or hand) and thus it is not possible to evaluate associations 
between site of osteoarthritis and expenditures associated with it.  Absenteeism is self-
reported in MEPS and this could cause variations while estimating absenteeism costs.  
Conclusions 
The study findings indicate that osteoarthritis is associated with significant 
incremental health care resource utilization and incremental health care expenditures 
even after adjusting for age, gender, race, region, marital status, insurance, Charlson 
comorbidity score, hypertension, hyperlipidemia, anxiety and asthma.  Significant 
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incremental mean annual resource utilization associated with osteoarthritis for 
hospitalizations (0.07), outpatient visits (3.63 visits), and emergency room visits (0.09 
visits) were observed.  Considerable mean total annual incremental expenditures of 
$2,045.75 associated with osteoarthritis were observed.  The highest contributor to total 
direct expenditures were from hospital expenditures ($826.38), followed by outpatient 
expenditures ($658.94) and medication expenditures ($325.03).  Significant mean 
incremental annual absenteeism at 2.21 days and mean incremental annual absenteeism 
costs at $715.75 were attained in this current study.   These findings indicate that 
presence of osteoarthritis has a significant economic burden, through direct healthcare 
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Table A1. Unadjusted Annual Health Care Resource Utilization among Persons with Osteoarthritis by Age 
 ____________________________________________________________________________________________________________ 
  Under 35 35 to 44 45 to 54 55 to 64 65 and over 
  (n=45) (n=73) (n=195) (n=389) (n=651) 
 ____________ ___________   ____________  __________   ___________ 
  Mean Mean Mean Mean Mean  
Utilization Category (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)  
 ____________________________________________________________________________________________________________ 
Hospitalizations 0.28 0.15 0.19 0.22 0.28 
  (0.13 to 0.43) (0.05 to 0.25) (0.11 to 0.27) (0.16 to 0.27) (0.22 to 0.33) 
    
Hospital days 6.58 5.22 5.42 4.42 4.93 
  (2.35 to 7.03) (2.16 to 8.26) (1.63 to 9.21) (2.98 to 5.45) (3.85 to 6.01) 
 
Outpatient visits 0.82 0.65 0.95 1.25 1.32 
  (0.07 to 1.57) (0.22 to 1.08) (0.48 to 1.42) (0.75 to 1.25) (1.03 to 1.60) 
 
Emergency room visits 0.33 0.64 0.40 0.32 0.29 









Table A2. Unadjusted Annual Health Care Resource Utilization among Persons with 
Osteoarthritis by Gender 
 ______________________________________________________________________  
   Female Male 
   (N=952) (N=402) 
  ____________________   ____________________  
   Mean Mean 
Utilization Category (95% CI) (95% CI) 
 ______________________________________________________________________  
Hospitalizations 0.23 0.26  
   (0.19 to 0.26) (0.20 to 0.33) 
 
Hospital days 5.19 5.98  
   (4.10 to 6.27) (1.98 to 9.99) 
  
Outpatient visits 1.25 1.06 
   (0.97 to 1.52) (0.77 to 1.35) 
  
Emergency room visits 0.36 0.27 
   (0.31 to 0.42) (0.21 to 0.34) 
 ______________________________________________________________________  
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Table A3. Unadjusted Annual Health Care Resource Utilization among Persons with 
Osteoarthritis and Presence or Absence of Hypertension 
 ______________________________________________________________________  
   No Hypertension  Hypertension 
   (n=510) (n=844) 
  ____________________   ____________________  
   Mean Mean  
Utilization Category (95% CI) (95% CI) 
 ______________________________________________________________________  
Hospitalizations 0.17 0.27  
   (0.13 to 0.22) (0.23 to 0.32) 
 
Hospital days 6.69 4.98  
   (1.86 to 11.51) (3.98 to 5.98) 
  
Outpatient visits 1.07 1.27 
   (0.67 to 1.46) (1.02 to 1.51) 
  
Emergency room visits 0.28 0.36 
   (0.22 to 0.35) (0.31 to 0.42) 
 ______________________________________________________________________  
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Table A4. Unadjusted Annual Health Care Resource Utilization among Persons with 
Osteoarthritis and Presence or Absence of Hyperlipidemia 
 ______________________________________________________________________  
   No Hyperlipidemia Hyperlipidemia 
   (n=663) (n=691) 
  ____________________   ____________________  
   Mean Mean 
Utilization Category (95% CI) (95% CI) 
 ______________________________________________________________________  
Hospitalizations 0.19 0.28  
   (0.15 to 0.24) (0.23 to 0.33) 
 
Hospital days 5.70 5.28 
   (2.47 to 8.93) (4.03 to 6.52) 
  
Outpatient visits 1.14 1.25 
   (0.78 to 1.48) (1.00 to 1.49) 
  
Emergency room visits 0.33 0.34 




Table A5. Unadjusted Annual Health Care Resource Utilization among Persons with 
Osteoarthritis and Presence or Absence of Anxiety 
 ______________________________________________________________________  
   No Anxiety Anxiety 
   (n=1,150) (n=204) 
  ____________________   ____________________  
   Mean Mean  
Utilization Category (95% CI) (95% CI)  
 ______________________________________________________________________  
Hospitalizations 0.22 0.31  
   (0.21 to 0.25) (0.21 to 1.5) 
 
Hospital days 5.59 4.81 
   (3.79 to 7.40) (3.30 to 6.29) 
  
Outpatient visits 1.22 1.05 
   (0.97 to 1.46) (0.74 to 1.36) 
  
Emergency room visits 0.29 0.56 




Table A6. Unadjusted Annual Health Care Resource Utilization among Persons with 
Osteoarthritis and Presence or Absence of Asthma 
 ______________________________________________________________________  
   No Asthma Asthma 
   (n=1,150) (n=204) 
  ____________________   ____________________  
   Mean Mean  
Utilization Category (95% CI) (95% CI)  
 ______________________________________________________________________  
Hospitalizations 0.23 0.27  
   (0.20 to 0.27) (0.17 to 0.36) 
 
Hospital days 5.49 5.59 
   (3.71 to 7.14) (2.93 to 8.25) 
  
Outpatient visits 1.03 2.18 
   (0.87 to 1.19) (1.05 to 3.32) 
  
Emergency room visits 0.33 0.37 
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Table B1. Unadjusted Annual Health Care Expenditures in Dollars among Persons with Osteoarthritis by Age 
 ____________________________________________________________________________________________________________ 
  Under 35 35 to 44 45 to 54 55 to 64 65 and over 
  (n=46) (n=73) (n=195) (n=389) (n=651) 
 ____________ ____________  ____________ ____________ ____________ 
  Mean Mean Mean Mean Mean  
Expenditure Category (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)  
 ____________________________________________________________________________________________________________ 
Inpatient  3,365 1,742 4,805 4,396 2,912  
expenditures (684 to 6,046) (312 to 3,172) (3,806 to 10,322) (2,752 to 6,040) (2,259 to 3,564) 
 
Outpatient  3,090 3,052 2,726 3,778 3,108 
expenditures (211 to 5,968) (2,101 to 4,002) (2,070 to 3,382) (3,165 to 4,391) (2,639 to 3,576) 
 
Emergency room  323 557 298 329 242 
expenditures (56 to 591) (88 to 1,025) (155 to 410) (209 to 450) (164 to 319) 
     
Medication  838 1,430 3,304 2,147 2,428 
expenditures (511 to 1,165) (996 to 1,865) (2,181 to 4,467) (1,848 to 2,447) (2,150 to 2,707) 
 
Miscellaneous 79 67 157 157 229 
Expenditures (23 to 182) (36 to 98) (63 to 250) (67 to 246) (170 to 288)  
 
Total health care  7,695 6,849 11,290 10,809 8,921 








Table B2. Unadjusted Annual Health Care Expenditures in Dollars among Persons with 
Osteoarthritis by Gender 
 ______________________________________________________________________  
   Male Female 
   (n=402) (n=952) 
  ____________________   ____________________  
   Mean Mean 
Expenditure Category (95% CI) (95% CI) 
 ______________________________________________________________________  
Inpatient expenditures 3,505 3,587 
   (2,515 to 4,494) (2,259 to 4,916) 
 
Outpatient expenditures 3,056 3,320 
   (2,507 to 3,604)  (2,929 to 3,711) 
  
Emergency room expenditures 254 312 
   (142 to 366) (239 to 385) 
 
Medication expenditures 2,200 2,436 
   (1,744 to 2,655) (2,173 to 2,699) 
 
Miscellaneous expenditures 180 189 
   (131 to 354) (129 to 233) 
 
Total expenditures 9,195 9,844  




Table B3. Unadjusted Annual Health Care Expenditures in Dollars among Persons with 
Osteoarthritis and Presence or Absence of Hypertension 
 ______________________________________________________________________  
   No Hypertension Hypertension 
   (n=510) (n=844) 
  ____________________   ____________________  
   Mean Mean 
Expenditure Category (95% CI) (95% CI) 
 ______________________________________________________________________  
Inpatient expenditures 2,613 4,137  
   (1,725 to 3,501) (2,661 to 5,612) 
 
Outpatient expenditures 3,033 3,368 
   (2,538 to 3,528) (2,951 to 3,784) 
 
Emergency expenditures 263 314  
   (166 to 360) (235 to 392)  
  
Medication expenditures 2,100 2,526 
   (1,653 to 2,548) (2,278 to 2,775) 
 
Miscellaneous expenditures 191 180 
   (127 to 354) (127 to 233) 
 
Total expenditures 8,202 10,526  
   (6,982 to 9,243) (8,871 to 12,182)  
 ______________________________________________________________________ 
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Table B4. Unadjusted Annual Health Care Expenditures in Dollars among Persons with 
Osteoarthritis and Presence or Absence of Hyperlipidemia 
 ______________________________________________________________________  
   No Hyperlipidemia Hyperlipidemia 
   (n=663) (n=691) 
  ____________________   ____________________  
   Mean Mean  
Expenditure Category (95% CI) (95% CI) 
 ______________________________________________________________________  
Inpatient expenditures 2,690  4,496  
   (1,915 to 3,265) (2,692 to 6,301) 
 
Outpatient expenditures 2,876 3,593 
   (2,477 to 3,274)) (3,098 to 4,047) 
 
Emergency room expenditures 305 284  
   (208 to 402) (209 to 359)  
  
Medication expenditures 1,891 2,822  
   (1,541 to 2,241) (2,527 to 3,116) 
 
Miscellaneous expenditures 171 197 
   (105 to 236) (147 to 246) 
 
Total expenditures 7,835 11,393  
   (6,856 to 8,814) (9,393 to 13,393)  




Table B5. Unadjusted Annual Health Care Expenditures in Dollars among Persons with 
Osteoarthritis and Presence or Absence of Anxiety 
 ______________________________________________________________________  
   No Anxiety Anxiety 
   (n=1,150) (n=204) 
  ____________________   ____________________  
   Mean Mean 
Expenditure Category (95% CI) (95% CI) 
 ______________________________________________________________________  
Inpatient expenditures 3,488 3,985 
   (2,371 to 4,605) (2,380 to 5,590) 
 
Outpatient expenditures 3,135 3,845 
   (2,779 to 3,490) (3,154 to 4,536) 
 
Emergency room expenditures 260 488  
   (201 to 320) (260 to 717)  
  
Medication expenditures 2,106 3,832 
   (1,884 to 2,328) (2,988 to 4,675) 
 
Miscellaneous expenditures 188 160 
   (141 to 235) (209 to 212) 
 
Total health care expenditures 9,179 12,311  
   (7,914 to 10,444) (9,990 to 14,633)  
 ______________________________________________________________________  
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Table B6. Unadjusted Annual Health Care Expenditures in Dollars among Persons with 
Osteoarthritis and Presence or Absence of Asthma 
 ______________________________________________________________________  
   No Asthma Asthma 
   (n=1,162) (n=192) 
  ____________________   ____________________  
   Mean Mean  
Expenditure Category (95% CI) (95% CI)  
 ______________________________________________________________________  
Inpatient expenditures 3,705 2,701  
   (2,578 to 4,832) (1,643 to 3,759) 
 
Outpatient expenditures 3,084 4,193 
   (2,750 to 3,419) (3,206 to 5,180)  
 
Emergency room expenditures 219 317  
   (224 to 358) (172 to 461)  
  
Medication expenditures 2,105 3,947 
   (1,884 to 2,325) (3,060 to 4,834) 
 
Miscellaneous expenditures 195 120 
   (149 to 240) (32 to 209) 
 
Total health care expenditures 9,382 11,279  
   (8,099 to 10,865) (9,482 to 13,076)  
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